0001157647 false Q1 2022 --12-31 P3Y P1Y
P3Y P3Y P3Y P3Y P3Y P1Y P3Y P3Y P3Y P3Y P3Y P3Y 0001157647
2022-01-01 2022-03-31 0001157647 2022-05-02 0001157647 2022-03-31
0001157647 2021-12-31 0001157647 2021-01-01 2021-03-31 0001157647
us-gaap:CommonStockMember 2020-12-31 0001157647
us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001157647
wneb:EmployeeStockOwnershipPlanESOPPlanMember 2020-12-31 0001157647
us-gaap:DeferredCompensationShareBasedPaymentsMember 2020-12-31
0001157647 us-gaap:RetainedEarningsMember 2020-12-31 0001157647
us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31
0001157647 2020-12-31 0001157647 us-gaap:CommonStockMember
2021-12-31 0001157647 us-gaap:AdditionalPaidInCapitalMember
2021-12-31 0001157647 wneb:EmployeeStockOwnershipPlanESOPPlanMember
2021-12-31 0001157647
us-gaap:DeferredCompensationShareBasedPaymentsMember 2021-12-31
0001157647 us-gaap:RetainedEarningsMember 2021-12-31 0001157647
us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31
0001157647 us-gaap:CommonStockMember 2021-01-01 2021-03-31
0001157647 us-gaap:AdditionalPaidInCapitalMember 2021-01-01
2021-03-31 0001157647 wneb:EmployeeStockOwnershipPlanESOPPlanMember
2021-01-01 2021-03-31 0001157647
us-gaap:DeferredCompensationShareBasedPaymentsMember 2021-01-01
2021-03-31 0001157647 us-gaap:RetainedEarningsMember 2021-01-01
2021-03-31 0001157647
us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01
2021-03-31 0001157647 us-gaap:CommonStockMember 2022-01-01
2022-03-31 0001157647 us-gaap:AdditionalPaidInCapitalMember
2022-01-01 2022-03-31 0001157647
wneb:EmployeeStockOwnershipPlanESOPPlanMember 2022-01-01 2022-03-31
0001157647 us-gaap:DeferredCompensationShareBasedPaymentsMember
2022-01-01 2022-03-31 0001157647 us-gaap:RetainedEarningsMember
2022-01-01 2022-03-31 0001157647
us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01
2022-03-31 0001157647 us-gaap:CommonStockMember 2021-03-31
0001157647 us-gaap:AdditionalPaidInCapitalMember 2021-03-31
0001157647 wneb:EmployeeStockOwnershipPlanESOPPlanMember 2021-03-31
0001157647 us-gaap:DeferredCompensationShareBasedPaymentsMember
2021-03-31 0001157647 us-gaap:RetainedEarningsMember 2021-03-31
0001157647 us-gaap:AccumulatedOtherComprehensiveIncomeMember
2021-03-31 0001157647 2021-03-31 0001157647
us-gaap:CommonStockMember 2022-03-31 0001157647
us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001157647
wneb:EmployeeStockOwnershipPlanESOPPlanMember 2022-03-31 0001157647
us-gaap:DeferredCompensationShareBasedPaymentsMember 2022-03-31
0001157647 us-gaap:RetainedEarningsMember 2022-03-31 0001157647
us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-03-31
0001157647 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember
2022-03-31 0001157647
us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2021-12-31
0001157647 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember
2022-03-31 0001157647
us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2021-12-31
0001157647 wneb:GovernmentSponsoredEnterpriseObligationsMember
2022-03-31 0001157647 wneb:StateAndMunicipalBondsMember 2022-03-31
0001157647 us-gaap:CorporateDebtSecuritiesMember 2022-03-31
0001157647 us-gaap:DebtSecuritiesMember 2022-03-31 0001157647
wneb:GovernmentSponsoredMortgageBackedSecuritiesMember 2022-03-31
0001157647
wneb:USGovernmentGuaranteedMortgageBackedSecuritiesMember
2022-03-31 0001157647 us-gaap:MortgageBackedSecuritiesMember
2022-03-31 0001157647 us-gaap:USTreasurySecuritiesMember 2022-03-31
0001157647 wneb:GovernmentSponsoredEnterpriseObligationsMember
2021-12-31 0001157647 wneb:StateAndMunicipalBondsMember 2021-12-31
0001157647 us-gaap:CorporateDebtSecuritiesMember 2021-12-31
0001157647 us-gaap:DebtSecuritiesMember 2021-12-31 0001157647
wneb:GovernmentSponsoredMortgageBackedSecuritiesMember 2021-12-31
0001157647
wneb:USGovernmentGuaranteedMortgageBackedSecuritiesMember
2021-12-31 0001157647 us-gaap:MortgageBackedSecuritiesMember
2021-12-31 0001157647 us-gaap:USTreasurySecuritiesMember 2021-12-31
0001157647 wneb:CorporateBondsMember 2022-03-31 0001157647
us-gaap:CommercialRealEstateMember 2022-03-31 0001157647
us-gaap:CommercialRealEstateMember 2021-12-31 0001157647
us-gaap:ResidentialMortgageMember 2022-03-31 0001157647
us-gaap:ResidentialMortgageMember 2021-12-31 0001157647
us-gaap:HomeEquityMember 2022-03-31 0001157647
us-gaap:HomeEquityMember 2021-12-31 0001157647
us-gaap:ResidentialPortfolioSegmentMember 2022-03-31 0001157647
us-gaap:ResidentialPortfolioSegmentMember 2021-12-31 0001157647
wneb:CommercialAndIndustrialPaycheckProtectionProgramMember
2022-03-31 0001157647
wneb:CommercialAndIndustrialPaycheckProtectionProgramMember
2021-12-31 0001157647 wneb:CommercialAndIndustrialMember 2022-03-31
0001157647 wneb:CommercialAndIndustrialMember 2021-12-31 0001157647
us-gaap:CommercialAndIndustrialSectorMember 2022-03-31 0001157647
us-gaap:CommercialAndIndustrialSectorMember 2021-12-31 0001157647
us-gaap:ConsumerLoanMember 2022-03-31 0001157647
us-gaap:ConsumerLoanMember 2021-12-31 0001157647
us-gaap:CommercialRealEstateMember 2020-12-31 0001157647
us-gaap:ResidentialPortfolioSegmentMember 2020-12-31 0001157647
wneb:CommercialAndIndustrialMember 2020-12-31 0001157647
us-gaap:ConsumerLoanMember 2020-12-31 0001157647
wneb:UnallocatedMember 2020-12-31 0001157647
us-gaap:CommercialRealEstateMember 2021-01-01 2021-03-31 0001157647
us-gaap:ResidentialPortfolioSegmentMember 2021-01-01 2021-03-31
0001157647 wneb:CommercialAndIndustrialMember 2021-01-01 2021-03-31
0001157647 us-gaap:ConsumerLoanMember 2021-01-01 2021-03-31
0001157647 wneb:UnallocatedMember 2021-01-01 2021-03-31 0001157647
us-gaap:CommercialRealEstateMember 2021-03-31 0001157647
us-gaap:ResidentialPortfolioSegmentMember 2021-03-31 0001157647
wneb:CommercialAndIndustrialMember 2021-03-31 0001157647
us-gaap:ConsumerLoanMember 2021-03-31 0001157647
wneb:UnallocatedMember 2021-03-31 0001157647 wneb:UnallocatedMember
2021-12-31 0001157647 us-gaap:CommercialRealEstateMember 2022-01-01
2022-03-31 0001157647 us-gaap:ResidentialPortfolioSegmentMember
2022-01-01 2022-03-31 0001157647 wneb:CommercialAndIndustrialMember
2022-01-01 2022-03-31 0001157647 us-gaap:ConsumerLoanMember
2022-01-01 2022-03-31 0001157647 wneb:UnallocatedMember 2022-01-01
2022-03-31 0001157647 wneb:UnallocatedMember 2022-03-31 0001157647
wneb:TotalLoansNonPPEMember 2022-03-31 0001157647
wneb:TotalLoansNonPPEMember 2021-12-31 0001157647
us-gaap:CommercialRealEstateMember
us-gaap:FinancingReceivables30To59DaysPastDueMember 2022-03-31
0001157647 us-gaap:CommercialRealEstateMember
us-gaap:FinancingReceivables60To89DaysPastDueMember 2022-03-31
0001157647 us-gaap:CommercialRealEstateMember
us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMember
2022-03-31 0001157647 us-gaap:CommercialRealEstateMember
us-gaap:FinancialAssetPastDueMember 2022-03-31 0001157647
us-gaap:CommercialRealEstateMember
us-gaap:FinancialAssetNotPastDueMember 2022-03-31 0001157647
us-gaap:ResidentialMortgageMember
us-gaap:FinancingReceivables30To59DaysPastDueMember 2022-03-31
0001157647 us-gaap:ResidentialMortgageMember
us-gaap:FinancingReceivables60To89DaysPastDueMember 2022-03-31
0001157647 us-gaap:ResidentialMortgageMember
us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMember
2022-03-31 0001157647 us-gaap:ResidentialMortgageMember
us-gaap:FinancialAssetPastDueMember 2022-03-31 0001157647
us-gaap:ResidentialMortgageMember
us-gaap:FinancialAssetNotPastDueMember 2022-03-31 0001157647
us-gaap:HomeEquityMember
us-gaap:FinancingReceivables30To59DaysPastDueMember 2022-03-31
0001157647 us-gaap:HomeEquityMember
us-gaap:FinancingReceivables60To89DaysPastDueMember 2022-03-31
0001157647 us-gaap:HomeEquityMember
us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMember
2022-03-31 0001157647 us-gaap:HomeEquityMember
us-gaap:FinancialAssetPastDueMember 2022-03-31 0001157647
us-gaap:HomeEquityMember us-gaap:FinancialAssetNotPastDueMember
2022-03-31 0001157647 wneb:CommercialAndIndustrialMember
us-gaap:FinancingReceivables30To59DaysPastDueMember 2022-03-31
0001157647 wneb:CommercialAndIndustrialMember
us-gaap:FinancingReceivables60To89DaysPastDueMember 2022-03-31
0001157647 wneb:CommercialAndIndustrialMember
us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMember
2022-03-31 0001157647 wneb:CommercialAndIndustrialMember
us-gaap:FinancialAssetPastDueMember 2022-03-31 0001157647
wneb:CommercialAndIndustrialMember
us-gaap:FinancialAssetNotPastDueMember 2022-03-31 0001157647
us-gaap:ConsumerLoanMember
us-gaap:FinancingReceivables30To59DaysPastDueMember 2022-03-31
0001157647 us-gaap:ConsumerLoanMember
us-gaap:FinancingReceivables60To89DaysPastDueMember 2022-03-31
0001157647 us-gaap:ConsumerLoanMember
us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMember
2022-03-31 0001157647 us-gaap:ConsumerLoanMember
us-gaap:FinancialAssetPastDueMember 2022-03-31 0001157647
us-gaap:ConsumerLoanMember us-gaap:FinancialAssetNotPastDueMember
2022-03-31 0001157647
us-gaap:FinancingReceivables30To59DaysPastDueMember 2022-03-31
0001157647 us-gaap:FinancingReceivables60To89DaysPastDueMember
2022-03-31 0001157647
us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMember
2022-03-31 0001157647 us-gaap:FinancialAssetPastDueMember
2022-03-31 0001157647 us-gaap:FinancialAssetNotPastDueMember
2022-03-31 0001157647 us-gaap:CommercialRealEstateMember
us-gaap:FinancingReceivables30To59DaysPastDueMember 2021-12-31
0001157647 us-gaap:CommercialRealEstateMember
us-gaap:FinancingReceivables60To89DaysPastDueMember 2021-12-31
0001157647 us-gaap:CommercialRealEstateMember
us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMember
2021-12-31 0001157647 us-gaap:CommercialRealEstateMember
us-gaap:FinancialAssetPastDueMember 2021-12-31 0001157647
us-gaap:CommercialRealEstateMember
us-gaap:FinancialAssetNotPastDueMember 2021-12-31 0001157647
us-gaap:ResidentialMortgageMember
us-gaap:FinancingReceivables30To59DaysPastDueMember 2021-12-31
0001157647 us-gaap:ResidentialMortgageMember
us-gaap:FinancingReceivables60To89DaysPastDueMember 2021-12-31
0001157647 us-gaap:ResidentialMortgageMember
us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMember
2021-12-31 0001157647 us-gaap:ResidentialMortgageMember
us-gaap:FinancialAssetPastDueMember 2021-12-31 0001157647
us-gaap:ResidentialMortgageMember
us-gaap:FinancialAssetNotPastDueMember 2021-12-31 0001157647
us-gaap:HomeEquityMember
us-gaap:FinancingReceivables30To59DaysPastDueMember 2021-12-31
0001157647 us-gaap:HomeEquityMember
us-gaap:FinancingReceivables60To89DaysPastDueMember 2021-12-31
0001157647 us-gaap:HomeEquityMember
us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMember
2021-12-31 0001157647 us-gaap:HomeEquityMember
us-gaap:FinancialAssetPastDueMember 2021-12-31 0001157647
us-gaap:HomeEquityMember us-gaap:FinancialAssetNotPastDueMember
2021-12-31 0001157647 wneb:CommercialAndIndustrialMember
us-gaap:FinancingReceivables30To59DaysPastDueMember 2021-12-31
0001157647 wneb:CommercialAndIndustrialMember
us-gaap:FinancingReceivables60To89DaysPastDueMember 2021-12-31
0001157647 wneb:CommercialAndIndustrialMember
us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMember
2021-12-31 0001157647 wneb:CommercialAndIndustrialMember
us-gaap:FinancialAssetPastDueMember 2021-12-31 0001157647
wneb:CommercialAndIndustrialMember
us-gaap:FinancialAssetNotPastDueMember 2021-12-31 0001157647
us-gaap:ConsumerLoanMember
us-gaap:FinancingReceivables30To59DaysPastDueMember 2021-12-31
0001157647 us-gaap:ConsumerLoanMember
us-gaap:FinancingReceivables60To89DaysPastDueMember 2021-12-31
0001157647 us-gaap:ConsumerLoanMember
us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMember
2021-12-31 0001157647 us-gaap:ConsumerLoanMember
us-gaap:FinancialAssetPastDueMember 2021-12-31 0001157647
us-gaap:ConsumerLoanMember us-gaap:FinancialAssetNotPastDueMember
2021-12-31 0001157647
us-gaap:FinancingReceivables30To59DaysPastDueMember 2021-12-31
0001157647 us-gaap:FinancingReceivables60To89DaysPastDueMember
2021-12-31 0001157647
us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMember
2021-12-31 0001157647 us-gaap:FinancialAssetPastDueMember
2021-12-31 0001157647 us-gaap:FinancialAssetNotPastDueMember
2021-12-31 0001157647 us-gaap:HomeEquityMember 2022-01-01
2022-03-31 0001157647 us-gaap:HomeEquityMember 2021-01-01
2021-03-31 0001157647 wneb:ChicopeeBancorpIncMember 2021-12-31
0001157647 wneb:ChicopeeBancorpIncMember 2022-01-01 2022-03-31
0001157647 wneb:ChicopeeBancorpIncMember 2022-03-31 0001157647
us-gaap:CommercialRealEstateMember wneb:Pass11Member 2022-03-31
0001157647 us-gaap:ResidentialMortgageMember wneb:Pass11Member
2022-03-31 0001157647 us-gaap:HomeEquityMember wneb:Pass11Member
2022-03-31 0001157647 us-gaap:CommercialAndIndustrialSectorMember
wneb:Pass11Member 2022-03-31 0001157647 us-gaap:ConsumerLoanMember
wneb:Pass11Member 2022-03-31 0001157647 wneb:Pass11Member
2022-03-31 0001157647 us-gaap:CommercialRealEstateMember
wneb:SpecialMention11Member 2022-03-31 0001157647
us-gaap:ResidentialMortgageMember wneb:SpecialMention11Member
2022-03-31 0001157647 us-gaap:HomeEquityMember
wneb:SpecialMention11Member 2022-03-31 0001157647
us-gaap:CommercialAndIndustrialSectorMember
wneb:SpecialMention11Member 2022-03-31 0001157647
us-gaap:ConsumerLoanMember wneb:SpecialMention11Member 2022-03-31
0001157647 wneb:SpecialMention11Member 2022-03-31 0001157647
us-gaap:CommercialRealEstateMember wneb:Substandard11Member
2022-03-31 0001157647 us-gaap:ResidentialMortgageMember
wneb:Substandard11Member 2022-03-31 0001157647
us-gaap:HomeEquityMember wneb:Substandard11Member 2022-03-31
0001157647 us-gaap:CommercialAndIndustrialSectorMember
wneb:Substandard11Member 2022-03-31 0001157647
us-gaap:ConsumerLoanMember wneb:Substandard11Member 2022-03-31
0001157647 wneb:Substandard11Member 2022-03-31 0001157647
us-gaap:CommercialRealEstateMember wneb:Pass11Member 2021-12-31
0001157647 us-gaap:ResidentialMortgageMember wneb:Pass11Member
2021-12-31 0001157647 us-gaap:HomeEquityMember wneb:Pass11Member
2021-12-31 0001157647 us-gaap:CommercialAndIndustrialSectorMember
wneb:Pass11Member 2021-12-31 0001157647 us-gaap:ConsumerLoanMember
wneb:Pass11Member 2021-12-31 0001157647 wneb:Pass11Member
2021-12-31 0001157647 us-gaap:CommercialRealEstateMember
wneb:SpecialMention11Member 2021-12-31 0001157647
us-gaap:ResidentialMortgageMember wneb:SpecialMention11Member
2021-12-31 0001157647 us-gaap:HomeEquityMember
wneb:SpecialMention11Member 2021-12-31 0001157647
us-gaap:CommercialAndIndustrialSectorMember
wneb:SpecialMention11Member 2021-12-31 0001157647
us-gaap:ConsumerLoanMember wneb:SpecialMention11Member 2021-12-31
0001157647 wneb:SpecialMention11Member 2021-12-31 0001157647
us-gaap:CommercialRealEstateMember wneb:Substandard11Member
2021-12-31 0001157647 us-gaap:ResidentialMortgageMember
wneb:Substandard11Member 2021-12-31 0001157647
us-gaap:HomeEquityMember wneb:Substandard11Member 2021-12-31
0001157647 us-gaap:CommercialAndIndustrialSectorMember
wneb:Substandard11Member 2021-12-31 0001157647
us-gaap:ConsumerLoanMember wneb:Substandard11Member 2021-12-31
0001157647 wneb:Substandard11Member 2021-12-31 0001157647
us-gaap:CoreDepositsMember 2022-03-31 0001157647
us-gaap:CoreDepositsMember 2022-01-01 2022-03-31 0001157647
us-gaap:EmployeeStockOptionMember 2021-12-31 0001157647
us-gaap:EmployeeStockOptionMember 2022-01-01 2022-03-31 0001157647
us-gaap:EmployeeStockOptionMember 2022-03-31 0001157647
us-gaap:StockCompensationPlanMember 2014-05-14 0001157647
us-gaap:StockCompensationPlanMember
us-gaap:ShareBasedPaymentArrangementEmployeeMember 2022-01-01
2022-03-31 0001157647 us-gaap:StockCompensationPlanMember
srt:DirectorMember 2022-01-01 2022-03-31 0001157647
wneb:LongTermIncentiveProgram2019Member 2019-02-01 2019-02-28
0001157647 wneb:LongTermIncentiveProgram2019Member
wneb:TimeBasedSharesMember 2019-02-01 2019-02-28 0001157647
wneb:LongTermIncentiveProgram2019Member wneb:TimeBasedSharesMember
us-gaap:ShareBasedCompensationAwardTrancheOneMember 2019-02-01
2019-02-28 0001157647 wneb:LongTermIncentiveProgram2019Member
wneb:TimeBasedSharesMember
us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2019-02-01
2019-02-28 0001157647 wneb:LongTermIncentiveProgram2019Member
us-gaap:PerformanceSharesMember 2019-02-01 2019-02-28 0001157647
wneb:LongTermIncentiveProgram2019Member
us-gaap:PerformanceSharesMember wneb:ThresholdMember 2019-02-01
2019-02-28 0001157647 wneb:LongTermIncentiveProgram2019Member
us-gaap:PerformanceSharesMember wneb:TargetMember 2019-02-01
2019-02-28 0001157647 wneb:LongTermIncentiveProgram2019Member
us-gaap:PerformanceSharesMember srt:MaximumMember 2019-02-01
2019-02-28 0001157647 wneb:LongTermIncentiveProgram2019Member
us-gaap:PerformanceSharesMember 2022-02-01 2022-02-28 0001157647
wneb:LongTermIncentiveProgramCurrent2020Member 2020-02-01
2020-02-29 0001157647
wneb:LongTermIncentiveProgramCurrent2020Member
wneb:TimeBasedSharesMember 2020-02-01 2020-02-29 0001157647
wneb:LongTermIncentiveProgramCurrent2020Member
wneb:TimeBasedSharesMember
us-gaap:ShareBasedCompensationAwardTrancheOneMember 2020-02-01
2020-02-29 0001157647
wneb:LongTermIncentiveProgramCurrent2020Member
wneb:TimeBasedSharesMember
us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2020-02-01
2020-02-29 0001157647
wneb:LongTermIncentiveProgramCurrent2020Member
us-gaap:PerformanceSharesMember 2020-02-01 2020-02-29 0001157647
wneb:LongTermIncentiveProgramCurrent2020Member
us-gaap:PerformanceSharesMember wneb:ThresholdMember 2020-02-01
2020-02-29 0001157647
wneb:LongTermIncentiveProgramCurrent2020Member
us-gaap:PerformanceSharesMember wneb:TargetMember 2020-02-01
2020-02-29 0001157647
wneb:LongTermIncentiveProgramCurrent2020Member
us-gaap:PerformanceSharesMember srt:MaximumMember 2020-02-01
2020-02-29 0001157647
wneb:LongTermIncentiveProgramCurrent2021Member srt:DirectorMember
2021-02-01 2021-02-28 0001157647
wneb:StockCompensationPlan2021Member 2021-05-31 0001157647
wneb:LongTermIncentiveProgramCurrent2021Member 2021-05-01
2021-05-31 0001157647
wneb:LongTermIncentiveProgramCurrent2021Member
wneb:TimeBasedSharesMember 2021-05-01 2021-05-31 0001157647
wneb:LongTermIncentiveProgramCurrent2021Member
us-gaap:PerformanceSharesMember 2021-05-01 2021-05-31 0001157647
wneb:LongTermIncentiveProgramCurrent2022Member 2022-03-01
2022-03-31 0001157647
wneb:LongTermIncentiveProgramCurrent2022Member
wneb:TimeBasedSharesMember 2022-03-01 2022-03-31 0001157647
wneb:LongTermIncentiveProgramCurrent2022Member
wneb:TimeBasedSharesMember
us-gaap:ShareBasedCompensationAwardTrancheOneMember 2022-03-01
2022-03-31 0001157647
wneb:LongTermIncentiveProgramCurrent2022Member
wneb:TimeBasedSharesMember
us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2022-03-01
2022-03-31 0001157647
wneb:LongTermIncentiveProgramCurrent2022Member
us-gaap:PerformanceSharesMember 2022-03-01 2022-03-31 0001157647
wneb:StockCompensationPlan2021Member 2022-03-31 0001157647
wneb:ThresholdMember wneb:LongTermIncentiveProgram2019Member
2019-01-01 2019-12-31 0001157647 wneb:TargetMember
wneb:LongTermIncentiveProgram2019Member 2019-01-01 2019-12-31
0001157647 wneb:StretchMember
wneb:LongTermIncentiveProgram2019Member 2019-01-01 2019-12-31
0001157647 wneb:ThresholdMember
wneb:LongTermIncentiveProgramCurrent2020Member 2020-01-01
2020-12-31 0001157647 wneb:TargetMember
wneb:LongTermIncentiveProgramCurrent2020Member 2020-01-01
2020-12-31 0001157647 wneb:StretchMember
wneb:LongTermIncentiveProgramCurrent2020Member 2020-01-01
2020-12-31 0001157647 wneb:ThresholdMember
wneb:LongTermIncentiveProgramCurrent2021Member 2021-01-01
2021-12-31 0001157647 wneb:TargetMember
wneb:LongTermIncentiveProgramCurrent2021Member 2021-01-01
2021-12-31 0001157647 wneb:StretchMember
wneb:LongTermIncentiveProgramCurrent2021Member 2021-01-01
2021-12-31 0001157647 wneb:ThresholdMember
wneb:LongTermIncentiveProgramCurrent2022Member 2022-01-01
2022-03-31 0001157647 wneb:TargetMember
wneb:LongTermIncentiveProgramCurrent2022Member 2022-01-01
2022-03-31 0001157647 wneb:StretchMember
wneb:LongTermIncentiveProgramCurrent2022Member 2022-01-01
2022-03-31 0001157647 us-gaap:RestrictedStockMember 2021-12-31
0001157647 us-gaap:RestrictedStockMember 2022-01-01 2022-03-31
0001157647 us-gaap:RestrictedStockMember 2022-03-31 0001157647
us-gaap:RestrictedStockMember 2020-12-31 0001157647
us-gaap:RestrictedStockMember 2021-01-01 2021-03-31 0001157647
us-gaap:RestrictedStockMember 2021-03-31 0001157647
us-gaap:FederalHomeLoanBankCertificatesAndObligationsFHLBMember
srt:MaximumMember 2022-03-31 0001157647 us-gaap:LineOfCreditMember
2022-03-31 0001157647 us-gaap:LineOfCreditMember 2021-12-31
0001157647 wneb:FederalReserveBankDiscountWindowMember 2022-03-31
0001157647 wneb:FederalReserveBankDiscountWindowMember 2021-12-31
0001157647 wneb:Bank1Member 2022-03-31 0001157647 wneb:Bank1Member
2021-12-31 0001157647 wneb:BankMember 2022-03-31 0001157647
wneb:BankMember 2021-12-31 0001157647
us-gaap:FederalHomeLoanBankAdvancesMember 2022-03-31 0001157647
us-gaap:FederalHomeLoanBankAdvancesMember 2021-12-31 0001157647
us-gaap:SubordinatedDebtMember 2021-04-20 0001157647
us-gaap:SubordinatedDebtMember
us-gaap:DebtInstrumentRedemptionPeriodOneMember 2022-03-31
0001157647 us-gaap:SubordinatedDebtMember 2022-01-01 2022-03-31
0001157647 us-gaap:SubordinatedDebtMember
us-gaap:DebtInstrumentRedemptionPeriodTwoMember 2022-01-01
2022-03-31 0001157647 us-gaap:SubordinatedDebtMember 2022-03-31
0001157647 us-gaap:PensionPlansDefinedBenefitMember 2022-01-01
2022-03-31 0001157647 us-gaap:NondesignatedMember
wneb:LoanLevelSwapsDealerMember 2022-03-31 0001157647
us-gaap:NondesignatedMember wneb:LoanLevelSwapsDealerMember
2022-01-01 2022-03-31 0001157647 us-gaap:NondesignatedMember
wneb:LoanLevelSwapsBorrowerMember 2022-03-31 0001157647
us-gaap:NondesignatedMember wneb:LoanLevelSwapsBorrowerMember
2022-01-01 2022-03-31 0001157647 us-gaap:NondesignatedMember
wneb:ForwardStartingLoanLevelSwapsDealerMember 2022-03-31
0001157647 us-gaap:NondesignatedMember
wneb:ForwardStartingLoanLevelSwapsDealerMember 2022-01-01
2022-03-31 0001157647 us-gaap:NondesignatedMember
wneb:ForwardStartingLoanLevelSwapsBorrowerMember 2022-03-31
0001157647 us-gaap:NondesignatedMember
wneb:ForwardStartingLoanLevelSwapsBorrowerMember 2022-01-01
2022-03-31 0001157647 us-gaap:NondesignatedMember
wneb:LoanLevelSwapsDealerMember 2021-12-31 0001157647
us-gaap:NondesignatedMember wneb:LoanLevelSwapsDealerMember
2021-01-01 2021-12-31 0001157647 us-gaap:NondesignatedMember
wneb:LoanLevelSwapsBorrowerMember 2021-12-31 0001157647
us-gaap:NondesignatedMember wneb:LoanLevelSwapsBorrowerMember
2021-01-01 2021-12-31 0001157647 us-gaap:NondesignatedMember
wneb:ForwardStartingLoanLevelSwapsDealerMember 2021-12-31
0001157647 us-gaap:NondesignatedMember
wneb:ForwardStartingLoanLevelSwapsDealerMember 2021-01-01
2021-12-31 0001157647 us-gaap:NondesignatedMember
wneb:ForwardStartingLoanLevelSwapsBorrowerMember 2021-12-31
0001157647 us-gaap:NondesignatedMember
wneb:ForwardStartingLoanLevelSwapsBorrowerMember 2021-01-01
2021-12-31 0001157647 us-gaap:NondesignatedMember
wneb:InterestRateSwapAgreementMember
wneb:CustomersDerivativesMember 2022-03-31 0001157647
us-gaap:NondesignatedMember wneb:InterestRateSwapAgreementMember
wneb:CounterpartiesDerivativesMember 2022-03-31 0001157647
us-gaap:NondesignatedMember us-gaap:OtherAssetsMember 2022-03-31
0001157647 us-gaap:NondesignatedMember
us-gaap:OtherLiabilitiesMember 2022-03-31 0001157647
us-gaap:NondesignatedMember wneb:InterestRateSwapAgreementMember
wneb:CustomersDerivativesMember 2021-12-31 0001157647
us-gaap:NondesignatedMember wneb:InterestRateSwapAgreementMember
wneb:CounterpartiesDerivativesMember 2021-12-31 0001157647
us-gaap:NondesignatedMember us-gaap:OtherAssetsMember 2021-12-31
0001157647 us-gaap:NondesignatedMember
us-gaap:OtherLiabilitiesMember 2021-12-31 0001157647
us-gaap:InterestRateSwapMember 2022-01-01 2022-03-31 0001157647
us-gaap:InterestRateSwapMember 2021-01-01 2021-03-31 0001157647
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:FairValueInputsLevel1Member 2022-03-31 0001157647
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:FairValueInputsLevel2Member 2022-03-31 0001157647
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:FairValueInputsLevel3Member 2022-03-31 0001157647
us-gaap:FairValueMeasurementsRecurringMember 2022-03-31 0001157647
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:FairValueInputsLevel1Member 2021-12-31 0001157647
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:FairValueInputsLevel2Member 2021-12-31 0001157647
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:FairValueInputsLevel3Member 2021-12-31 0001157647
us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001157647
us-gaap:CarryingReportedAmountFairValueDisclosureMember 2022-03-31
0001157647 us-gaap:FairValueInputsLevel1Member 2022-03-31
0001157647 us-gaap:FairValueInputsLevel2Member 2022-03-31
0001157647 us-gaap:FairValueInputsLevel3Member 2022-03-31
0001157647 us-gaap:CarryingReportedAmountFairValueDisclosureMember
2021-12-31 0001157647 us-gaap:FairValueInputsLevel1Member
2021-12-31 0001157647 us-gaap:FairValueInputsLevel2Member
2021-12-31 0001157647 us-gaap:FairValueInputsLevel3Member
2021-12-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares
xbrli:pure wneb:N iso4217:USD wneb:Loan
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
10-Q
|
☒ |
QUARTERLY
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
ACT OF 1934 |
For
the quarterly period ended
March 31, 2022
or
|
☐ |
TRANSITION
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
ACT OF 1934 |
For
the transition period from ___________ to ___________
Commission
File Number:
001-16767
Western New England Bancorp, Inc.
(Exact
name of registrant as specified in its charter)
Massachusetts |
|
73-1627673 |
(State
or other jurisdiction of incorporation or organization) |
|
(IRS
Employer Identification Number) |
141 Elm Street,
Westfield,
Massachusetts |
|
01086 |
(Address
of principal executive offices) |
|
(Zip
Code) |
(413)
568-1911
(Registrant’s
telephone number, including area code)
(Former
name, former address and former fiscal year, if changed since last
report)
Securities
registered pursuant to Section 12(b) of the Act:
Title
of each class |
Trading
Symbol(s) |
Name
of each exchange on which registered |
Common Stock, $0.01 par value per share |
WNEB |
NASDAQ |
Indicate
by check mark whether the registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities
Exchange Act of 1934 during the preceding 12 months (or for
such shorter period that the registrant was required to file such
reports), and (2) has been subject to such filing requirements
for the past 90 days.
Yes ☒ No ☐
Indicate
by check mark whether the registrant has submitted electronically
every Interactive Data File required to be submitted pursuant to
Rule 405 of Regulation S-T (§ 232.405 of this
chapter) during the preceding 12 months (or for such shorter
period that the registrant was required to submit such
files).
Yes ☒ No ☐
Indicate
by check mark whether the registrant is a large accelerated filer,
an accelerated filer, a non-accelerated filer, a smaller reporting
company, or an emerging growth company. See the definitions of
“large accelerated filer,” “accelerated filer,” “smaller reporting
company,” and “emerging growth company” in Rule 12b-2 of the
Exchange Act.
Large accelerated filer ☐ |
Accelerated filer ☒ |
Non-accelerated
filer ☐ |
Smaller reporting company ☒ |
|
Emerging
growth company ☐ |
If an
emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided
pursuant to Section 13(a) of the Exchange
Act. ☐
Indicate
by check mark whether the registrant is a shell company (as defined
in Rule 12b-2 of the Exchange
Act). Yes ☐ No ☒
At
May 2, 2022 the registrant had
22,642,038 shares of common stock, $0.01 par value,
issued and outstanding.
TABLE
OF CONTENTS
FORWARD–LOOKING STATEMENTS
We
may, from time to time, make written or oral “forward-looking
statements” within the meaning of the Private Securities Litigation
Reform Act of 1995, including statements contained in our filings
with the Securities and Exchange Commission (the “SEC”), our
reports to shareholders and in other communications by us. This
Quarterly Report on Form 10-Q contains “forward-looking statements”
with respect to the Company’s
financial condition, liquidity, results of operations, future
performance, business, measures being taken in response to the
coronavirus disease 2019 (“COVID-19”) pandemic and the impact of
COVID-19 on the Company’s business. Forward-looking
statements may be identified by the use of such words as “believe,”
“expect,” “anticipate,” “should,” “planned,” “estimated,” and
“potential.” Examples of forward-looking statements include, but
are not limited to, estimates with respect to our financial
condition, results of operations and business that are subject to
various factors which could cause actual results to differ
materially from these estimates. These factors include, but are not
limited to:
|
● |
the
duration and scope of the COVID-19 pandemic and the local, national
and global impact of COVID-19; |
|
● |
actions
governments, businesses and individuals take in response to the
COVID-19 pandemic; |
|
● |
the
speed and effectiveness of any COVID-19 vaccines and treatment
developments and their deployment, including public adoption rates
of any COVID-19 vaccines; |
|
● |
the
emergence of new COVID-19 variants, such as the Omicron variant,
and the response thereto; |
|
● |
the
pace of recovery when the COVID-19 pandemic subsides; |
|
● |
changes
in the interest rate environment that reduce margins; |
|
● |
the
effect on our operations of governmental legislation and
regulation, including changes in accounting regulation or
standards, the nature and timing of the adoption and effectiveness
of new requirements under the Dodd-Frank Act Wall Street Reform and
Consumer Protection Act of 2010 (“Dodd-Frank Act”), Basel
guidelines, capital requirements and other applicable laws and
regulations; |
|
● |
the
highly competitive industry and market area in which we
operate; |
|
● |
general
economic conditions, either nationally or regionally, resulting in,
among other things, a deterioration in credit quality; |
|
● |
changes
in business conditions and inflation; |
|
● |
changes
in credit market conditions; |
|
● |
the
inability to realize expected cost savings or achieve other
anticipated benefits in connection with business combinations and
other acquisitions; |
|
● |
changes
in the securities markets which affect investment management
revenues; |
|
● |
increases
in Federal Deposit Insurance Corporation deposit insurance premiums
and assessments; |
|
● |
changes
in technology used in the banking business; |
|
● |
the
soundness of other financial services institutions which may
adversely affect our credit risk; |
|
● |
certain
of our intangible assets may become impaired in the
future; |
|
● |
our
controls and procedures may fail or be circumvented; |
|
● |
new
lines of business or new products and services, which may subject
us to additional risks; |
|
● |
changes
in key management personnel which may adversely impact our
operations; |
|
● |
severe
weather, natural disasters, acts of war or terrorism and other
external events which could significantly impact our business;
and |
|
● |
other
factors detailed from time to time in our SEC filings. |
Although
we believe that the expectations reflected in such forward-looking
statements are reasonable, actual results may differ materially
from the results discussed in these forward-looking statements. You
are cautioned not to place undue reliance on these forward-looking
statements, which speak only as of the date hereof. We do not
undertake any obligation to republish revised forward-looking
statements to reflect events or circumstances after the date hereof
or to reflect the occurrence of unanticipated events, except to the
extent required by law.
PART I – FINANCIAL INFORMATION
ITEM 1: FINANCIAL STATEMENTS.
WESTERN
NEW ENGLAND BANCORP, INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS - UNAUDITED
(Dollars
in thousands, except per share data)
|
|
March 31, |
|
|
December 31, |
|
|
|
2022 |
|
|
2021 |
|
ASSETS |
|
|
|
|
|
|
|
|
Cash and due from banks |
|
$ |
16,983 |
|
|
$ |
15,233 |
|
Federal funds sold |
|
|
2,456 |
|
|
|
4,901 |
|
Interest-bearing deposits and other short-term investments |
|
|
43,459 |
|
|
|
83,322 |
|
Cash and cash equivalents |
|
|
62,898 |
|
|
|
103,456 |
|
|
|
|
|
|
|
|
|
|
Available-for-sale securities, at fair value |
|
|
173,910 |
|
|
|
194,352 |
|
Held-to-maturity securities, at amortized cost (Fair value of
$220,279 and
$219,748
at March 31, 2022 and December 31, 2021, respectively) |
|
|
237,575 |
|
|
|
222,272 |
|
Marketable equity securities, at fair value |
|
|
11,643 |
|
|
|
11,896 |
|
Federal Home Loan Bank of Boston stock and other restricted stock,
at cost |
|
|
2,594 |
|
|
|
2,594 |
|
Loans, net of allowance for loan losses of $19,308 at March,
31, 2022 and $19,787
at December 31, 2021 |
|
|
1,906,977 |
|
|
|
1,844,929 |
|
Premises and equipment, net |
|
|
25,686 |
|
|
|
26,162 |
|
Accrued interest receivable |
|
|
7,723 |
|
|
|
7,775 |
|
Bank-owned life insurance |
|
|
73,343 |
|
|
|
72,895 |
|
Deferred tax asset, net |
|
|
14,981 |
|
|
|
12,092 |
|
Goodwill |
|
|
12,487 |
|
|
|
12,487 |
|
Core deposit intangible |
|
|
2,469 |
|
|
|
2,563 |
|
Other assets |
|
|
23,152 |
|
|
|
24,952 |
|
TOTAL ASSETS |
|
$ |
2,555,438 |
|
|
$ |
2,538,425 |
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND SHAREHOLDERS' EQUITY |
|
|
|
|
|
|
|
|
LIABILITIES: |
|
|
|
|
|
|
|
|
Deposits: |
|
|
|
|
|
|
|
|
Non-interest-bearing |
|
$ |
630,208 |
|
|
$ |
641,284 |
|
Interest-bearing |
|
|
1,647,956 |
|
|
|
1,615,614 |
|
Total deposits |
|
|
2,278,164 |
|
|
|
2,256,898 |
|
|
|
|
|
|
|
|
|
|
Federal Home Loan Bank advances |
|
|
1,686 |
|
|
|
2,653 |
|
Subordinated debt |
|
|
19,643 |
|
|
|
19,633 |
|
Securities pending settlement |
|
|
146 |
|
|
|
— |
|
Other liabilities |
|
|
36,736 |
|
|
|
35,553 |
|
TOTAL LIABILITIES |
|
|
2,336,375 |
|
|
|
2,314,737 |
|
|
|
|
|
|
|
|
|
|
SHAREHOLDERS' EQUITY: |
|
|
|
|
|
|
|
|
Preferred
stock - $0.01
par value,
5,000,000 shares
authorized,
none outstanding at March 31, 2022 and December
31, 2021 |
|
|
— |
|
|
|
— |
|
Common stock - $0.01
par value,
75,000,000 shares
authorized, 22,742,189 shares
issued and outstanding at March 31, 2022;
22,656,515 shares issued and outstanding at December
31, 2021 |
|
|
227 |
|
|
|
227 |
|
Additional paid-in capital |
|
|
133,459 |
|
|
|
132,821 |
|
Unearned compensation – Employee Stock Ownership Plan |
|
|
(3,307 |
) |
|
|
(3,441 |
) |
Unearned compensation - Equity Incentive Plan |
|
|
(1,943 |
) |
|
|
(981 |
) |
Retained earnings |
|
|
111,358 |
|
|
|
107,376 |
|
Accumulated other comprehensive loss |
|
|
(20,731 |
) |
|
|
(12,314 |
) |
TOTAL SHAREHOLDERS’ EQUITY |
|
|
219,063 |
|
|
|
223,688 |
|
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY |
|
$ |
2,555,438 |
|
|
$ |
2,538,425 |
|
See accompanying notes to unaudited consolidated financial
statements.
WESTERN
NEW ENGLAND BANCORP, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF NET INCOME –
UNAUDITED
(Dollars
in thousands, except per share data)
|
|
|
|
|
|
|
|
|
|
|
Three
Months |
|
|
|
Ended March 31, |
|
|
|
2022 |
|
|
2021 |
|
Interest
and dividend income: |
|
|
|
|
|
|
|
|
Residential and commercial real estate loans |
|
$ |
15,343 |
|
|
$ |
14,509 |
|
Commercial and industrial loans |
|
|
2,544 |
|
|
|
4,542 |
|
Consumer
loans |
|
|
60 |
|
|
|
69 |
|
Debt
securities, taxable |
|
|
1,923 |
|
|
|
824 |
|
Debt
securities, tax-exempt |
|
|
3 |
|
|
|
3 |
|
Marketable equity securities |
|
|
24 |
|
|
|
27 |
|
Other
investments |
|
|
25 |
|
|
|
35 |
|
Short-term investments |
|
|
21 |
|
|
|
24 |
|
Total interest and dividend income |
|
|
19,943 |
|
|
|
20,033 |
|
|
|
|
|
|
|
|
|
|
Interest
expense: |
|
|
|
|
|
|
|
|
Deposits |
|
|
992 |
|
|
|
1,734 |
|
Long-term
debt |
|
|
— |
|
|
|
273 |
|
Subordinated debt |
|
|
253 |
|
|
|
— |
|
Total interest expense |
|
|
1,245 |
|
|
|
2,007 |
|
Net interest and dividend income |
|
|
18,698 |
|
|
|
18,026 |
|
|
|
|
|
|
|
|
|
|
(Credit) provision for loan losses |
|
|
(425 |
) |
|
|
75 |
|
Net interest and dividend income after (credit) provision for loan
losses |
|
|
19,123 |
|
|
|
17,951 |
|
|
|
|
|
|
|
|
|
|
Non-interest income: |
|
|
|
|
|
|
|
|
Service
charges and fees |
|
|
2,174 |
|
|
|
1,883 |
|
Income
from bank-owned life insurance |
|
|
448 |
|
|
|
441 |
|
Loss on
available-for-sale securities, net |
|
|
(4 |
) |
|
|
(62 |
) |
Net
unrealized loss on marketable equity securities |
|
|
(276 |
) |
|
|
(89 |
) |
Gain on
sale of mortgages |
|
|
2 |
|
|
|
227 |
|
Gain on
non-marketable equity investments |
|
|
— |
|
|
|
546 |
|
Other income |
|
|
4 |
|
|
|
58 |
|
Total non-interest income |
|
|
2,348 |
|
|
|
3,004 |
|
|
|
|
|
|
|
|
|
|
Non-interest expense: |
|
|
|
|
|
|
|
|
Salaries and employees benefits |
|
|
8,239 |
|
|
|
7,682 |
|
Occupancy |
|
|
1,363 |
|
|
|
1,289 |
|
Furniture
and equipment |
|
|
543 |
|
|
|
490 |
|
Data
processing |
|
|
723 |
|
|
|
721 |
|
Professional fees |
|
|
577 |
|
|
|
544 |
|
FDIC
insurance assessment |
|
|
286 |
|
|
|
298 |
|
Advertising |
|
|
399 |
|
|
|
338 |
|
Other expenses |
|
|
2,326 |
|
|
|
1,965 |
|
Total non-interest expense |
|
|
14,456 |
|
|
|
13,327 |
|
Income tax provision |
|
|
1,696 |
|
|
|
1,837 |
|
Net
income |
|
$ |
5,319 |
|
|
$ |
5,791 |
|
|
|
|
|
|
|
|
|
|
Earnings per
common share: |
|
|
|
|
|
|
|
|
Basic earnings per share |
|
$ |
0.24 |
|
|
$ |
0.24 |
|
Weighted average shares
outstanding |
|
|
22,100,076 |
|
|
|
24,486,146 |
|
Diluted earnings per share |
|
$ |
0.24 |
|
|
$ |
0.24 |
|
Weighted average diluted shares
outstanding |
|
|
22,172,909 |
|
|
|
24,543,554 |
|
Dividends per share |
|
$ |
0.06 |
|
|
$ |
0.05 |
|
See accompanying notes to unaudited consolidated financial
statements.
WESTERN
NEW ENGLAND BANCORP, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) –
UNAUDITED
(Dollars
in thousands)
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, |
|
|
|
2022 |
|
|
2021 |
|
|
|
|
|
|
|
|
Net income |
|
$ |
5,319 |
|
|
$ |
5,791 |
|
|
|
|
|
|
|
|
|
|
Other comprehensive income (loss): |
|
|
|
|
|
|
|
|
Unrealized losses on available-for-sale securities: |
|
|
|
|
|
|
|
|
Unrealized holding losses |
|
|
(11,468 |
) |
|
|
(4,469 |
) |
Reclassification
adjustment for net losses realized in income (1) |
|
|
4 |
|
|
|
62 |
|
Unrealized losses |
|
|
(11,464 |
) |
|
|
(4,407 |
) |
Tax effect |
|
|
2,934 |
|
|
|
1,081 |
|
Net-of-tax amount |
|
|
(8,530 |
) |
|
|
(3,326 |
) |
|
|
|
|
|
|
|
|
|
Cash flow hedges: |
|
|
|
|
|
|
|
|
Reclassification adjustment for termination fee realized in
interest expense |
|
|
— |
|
|
|
140 |
|
Tax effect |
|
|
— |
|
|
|
(39 |
) |
Net-of-tax amount |
|
|
— |
|
|
|
101 |
|
|
|
|
|
|
|
|
|
|
Defined benefit pension plan: |
|
|
|
|
|
|
|
|
Amortization of defined benefit plans actuarial loss |
|
|
158 |
|
|
|
234 |
|
Tax effect |
|
|
(45 |
) |
|
|
(66 |
) |
Net-of-tax amount |
|
|
113 |
|
|
|
168 |
|
|
|
|
|
|
|
|
|
|
Other comprehensive loss |
|
|
(8,417 |
) |
|
|
(3,057 |
) |
|
|
|
|
|
|
|
|
|
Comprehensive (loss) income |
|
$ |
(3,098 |
) |
|
$ |
2,734 |
|
(1) |
|
Realized gains and losses on
available-for-sale securities are recognized as a component of
non-interest income. The tax effects applicable to net realized
gains and losses were $(1,000)
and $(14,000)
for the three months ended March 31, 2022 and 2021,
respectively. |
(1) |
|
Realized
gains and losses on available-for-sale securities are recognized as
a component of non-interest income. The tax effects applicable to
net realized gains and losses were $(1,000) and $(14,000) for the
three months ended March 31, 2022 and 2021, respectively. |
See
accompanying notes to unaudited consolidated financial
statements.
WESTERN
NEW ENGLAND BANCORP, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF
CHANGES IN SHAREHOLDERS' EQUITY - UNAUDITED
THREE
MONTHS ENDED MARCH 31, 2022 AND 2021
(Dollars in
thousands, except per share data)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common
Stock |
|
|
Additional |
|
|
Unearned |
|
|
Unearned
Compensation- |
|
|
|
|
|
Accumulated
Other |
|
|
|
|
|
|
|
Shares |
|
|
Par Value |
|
|
Paid-in
Capital |
|
|
Compensation-
ESOP |
|
|
Equity
Incentive Plan |
|
|
Retained
Earnings |
|
|
Comprehensive
Loss |
|
|
Total |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
BALANCE
AT DECEMBER 31, 2020 |
|
|
25,276,193 |
|
|
$ |
253 |
|
|
$ |
154,549 |
|
|
$ |
(3,997 |
) |
|
$ |
(1,240 |
) |
|
$ |
88,354 |
|
|
$ |
(11,279 |
) |
|
$ |
226,640 |
|
Comprehensive
income |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
5,791 |
|
|
|
(3,057 |
) |
|
|
2,734 |
|
Common
stock held by ESOP committed to be released (81,893
shares) |
|
|
— |
|
|
|
— |
|
|
|
8 |
|
|
|
139 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
147 |
|
Share-based
compensation - equity incentive plan |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
231 |
|
|
|
— |
|
|
|
— |
|
|
|
231 |
|
Forfeited
equity incentive plan shares reissued (19,154
shares) |
|
|
— |
|
|
|
— |
|
|
|
(212 |
) |
|
|
— |
|
|
|
212 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Common
stock repurchased |
|
|
(711,635 |
) |
|
|
(7 |
) |
|
|
(5,770 |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(5,777 |
) |
Issuance
of common stock in connection with stock option
exercises |
|
|
19,400 |
|
|
|
— |
|
|
|
113 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
113 |
|
Issuance
of common stock in connection with equity incentive plan (19,827
shares) |
|
|
— |
|
|
|
— |
|
|
|
162 |
|
|
|
— |
|
|
|
(162 |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
Cash
dividends declared and paid on common stock ($0.05
per share) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(1,232 |
) |
|
|
— |
|
|
|
(1,232 |
) |
BALANCE
AT
MARCH 31, 2021 |
|
|
24,583,958 |
|
|
$ |
246 |
|
|
$ |
148,850 |
|
|
$ |
(3,858 |
) |
|
$ |
(959 |
) |
|
$ |
92,913 |
|
|
$ |
(14,336 |
) |
|
$ |
222,856 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
BALANCE
AT DECEMBER 31, 2021 |
|
|
22,656,515 |
|
|
$ |
227 |
|
|
$ |
132,821 |
|
|
$ |
(3,441 |
) |
|
$ |
(981 |
) |
|
$ |
107,376 |
|
|
$ |
(12,314 |
) |
|
$ |
223,688 |
|
Comprehensive
income |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
5,319 |
|
|
|
(8,417 |
) |
|
|
(3,098 |
) |
Common
stock held by ESOP committed to be released (78,526
shares) |
|
|
— |
|
|
|
— |
|
|
|
45 |
|
|
|
134 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
179 |
|
Share-based
compensation - equity incentive plan |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
301 |
|
|
|
— |
|
|
|
— |
|
|
|
301 |
|
Forfeited
equity incentive plan shares (6,651
shares) |
|
|
— |
|
|
|
— |
|
|
|
(57 |
) |
|
|
— |
|
|
|
57 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Forfeited
equity incentive plan shares reissued (7,289
shares) |
|
|
— |
|
|
|
— |
|
|
|
71 |
|
|
|
— |
|
|
|
(71 |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
Common
stock repurchased |
|
|
(132,358 |
) |
|
|
(2 |
) |
|
|
(1,178 |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(1,180 |
) |
Issuance
of common stock in connection with stock option
exercises |
|
|
80,881 |
|
|
|
1 |
|
|
|
509 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
510 |
|
Issuance
of common stock in connection with equity incentive
plan |
|
|
137,151 |
|
|
|
1 |
|
|
|
1,248 |
|
|
|
— |
|
|
|
(1,249 |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
Cash
dividends declared and paid on common stock ($0.06
per share) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(1,337 |
) |
|
|
— |
|
|
|
(1,337 |
) |
BALANCE
AT
MARCH 31, 2022 |
|
|
22,742,189 |
|
|
$ |
227 |
|
|
$ |
133,459 |
|
|
$ |
(3,307 |
) |
|
$ |
(1,943 |
) |
|
$ |
111,358 |
|
|
$ |
(20,731 |
) |
|
$ |
219,063 |
|
See
accompanying notes to unaudited consolidated financial
statements.
WESTERN
NEW ENGLAND BANCORP, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF
CASH FLOWS - UNAUDITED
(Dollars in
thousands)
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, |
|
|
|
2022 |
|
|
2021 |
|
CASH FLOWS FROM OPERATING ACTIVITIES: |
|
|
|
|
|
|
|
|
Net income |
|
$ |
5,319 |
|
|
$ |
5,791 |
|
Adjustments to reconcile net income to net cash provided by
operating activities: |
|
|
|
|
|
|
|
|
(Credit) provision for loan losses |
|
|
(425 |
) |
|
|
75 |
|
Depreciation and amortization of premises and equipment |
|
|
584 |
|
|
|
584 |
|
(Accretion) amortization of purchase accounting adjustments,
net |
|
|
(29 |
) |
|
|
55 |
|
Amortization of core deposit intangible |
|
|
94 |
|
|
|
93 |
|
Net amortization of premiums and discounts on securities and
mortgage loans |
|
|
441 |
|
|
|
670 |
|
Net amortization of premiums on subordinated debt |
|
|
10 |
|
|
|
— |
|
Share-based compensation expense |
|
|
301 |
|
|
|
231 |
|
ESOP expense |
|
|
179 |
|
|
|
147 |
|
Gain on sale of mortgages |
|
|
— |
|
|
|
(227 |
) |
Principal balance of loans originated for sale |
|
|
(277 |
) |
|
|
— |
|
Principal balance of loans sold |
|
|
277 |
|
|
|
— |
|
Net loss on available-for-sale securities |
|
|
4 |
|
|
|
62 |
|
Net change in unrealized loss on marketable equity securities |
|
|
276 |
|
|
|
89 |
|
Income from bank-owned life insurance |
|
|
(448 |
) |
|
|
(441 |
) |
Net change in: |
|
|
|
|
|
|
|
|
Accrued interest receivable |
|
|
52 |
|
|
|
(6 |
) |
Other assets |
|
|
(954 |
) |
|
|
2,603 |
|
Other liabilities |
|
|
1,661 |
|
|
|
1,276 |
|
Net cash provided by operating activities |
|
|
7,065 |
|
|
|
11,002 |
|
|
|
|
|
|
|
|
|
|
CASH FLOWS FROM INVESTING ACTIVITIES: |
|
|
|
|
|
|
|
|
Purchases of held-to-maturity securities |
|
|
(20,627 |
) |
|
|
(63,973 |
) |
Proceeds from calls, maturities and principal collections of
held-to-maturity securities |
|
|
5,190 |
|
|
|
— |
|
Purchases of available-for-sale securities |
|
|
— |
|
|
|
(15,821 |
) |
Proceeds from sales and redemption of available-for-sale
securities |
|
|
20 |
|
|
|
14 |
|
Proceeds from calls, maturities, and principal collections of
available-for-sale securities |
|
|
8,630 |
|
|
|
17,163 |
|
Loan originations and principal payments, net |
|
|
(61,603 |
) |
|
|
(5,205 |
) |
Redemption of Federal Home Loan Bank of Boston stock |
|
|
— |
|
|
|
668 |
|
Proceeds from sale of portfolio mortgages |
|
|
— |
|
|
|
7,801 |
|
Purchases of premises and equipment |
|
|
(118 |
) |
|
|
(907 |
) |
Proceeds from payout on bank-owned life insurance |
|
|
2,435 |
|
|
|
— |
|
Net cash used in investing activities |
|
|
(66,073 |
) |
|
|
(60,260 |
) |
|
|
|
|
|
|
|
|
|
CASH FLOWS FROM FINANCING ACTIVITIES: |
|
|
|
|
|
|
|
|
Net
increase in deposits |
|
|
21,275 |
|
|
|
116,012 |
|
Repayment of long-term debt |
|
|
(964 |
) |
|
|
(15,170 |
) |
Cash dividends paid on common stock |
|
|
(1,337 |
) |
|
|
(1,232 |
) |
Common stock repurchased |
|
|
(1,034 |
) |
|
|
(5,785 |
) |
Issuance of common stock in connection with stock option
exercises |
|
|
510 |
|
|
|
113 |
|
Net cash provided by financing activities |
|
|
18,450 |
|
|
|
93,938 |
|
|
|
|
|
|
|
|
|
|
NET CHANGE IN CASH AND CASH EQUIVALENTS: |
|
|
(40,558 |
) |
|
|
44,680 |
|
Beginning of period |
|
|
103,456 |
|
|
|
87,444 |
|
End of period |
|
$ |
62,898 |
|
|
$ |
132,124 |
|
|
|
|
|
|
|
|
|
|
Supplemental cash flow information: |
|
|
|
|
|
|
|
|
Interest paid |
|
$ |
1,267 |
|
|
$ |
2,046 |
|
Taxes paid |
|
|
1,020 |
|
|
|
828 |
|
Net
change in cash due to broker for common stock repurchased |
|
|
146 |
|
|
|
(8 |
) |
See the accompanying notes to unaudited consolidated financial
statements.
WESTERN
NEW ENGLAND BANCORP, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)
MARCH
31, 2022
1.
SUMMARY OF
SIGNIFICANT ACCOUNTING POLICIES
Nature of Operations and Basis of Presentation. Western
New England Bancorp, Inc. (“Western New England Bancorp,” “WNEB,”
“Company,” “we,” or “us”) is a Massachusetts-chartered stock
holding company for Westfield Bank, a federally-chartered savings
bank (“Bank”).
The
Bank operates 25
banking offices in Hampden and Hampshire counties in western
Massachusetts and Hartford and Tolland counties in northern
Connecticut, and its primary sources of revenue are interest income
from loans as well as interest income from investment securities.
The West Hartford Financial Services Center serves as the Company’s
Connecticut hub, housing Commercial Lending, Cash Management and a
Mortgage Loan Officer. The Bank’s deposits are insured up to the
maximum Federal Deposit Insurance Corporation (“FDIC”) coverage
limits.
Wholly-owned Subsidiaries of the Bank. Elm Street
Securities Corporation, WFD Securities, Inc. and CSB Colts, Inc.,
are Massachusetts chartered securities corporations, formed for the
primary purpose of holding qualified securities. WB Real Estate
Holdings, LLC, is a Massachusetts-chartered limited liability
company that holds real property acquired as security for debts
previously contracted by the Bank.
Principles of Consolidation. The consolidated financial
statements include the accounts of Western New England Bancorp, the
Bank, CSB Colts, Inc., Elm Street Securities Corporation, WB Real
Estate Holdings, LLC and WFD Securities, Inc. All material
intercompany balances and transactions have been eliminated in
consolidation.
Estimates. The preparation of consolidated financial
statements in conformity with accounting principles generally
accepted in the United States of America (“U.S. GAAP”) requires
management to make estimates and assumptions that affect the
reported amounts of assets and liabilities and disclosure of
contingent assets and liabilities at the date of the consolidated
financial statements and the reported amounts of income and
expenses for each. Actual results could differ from those
estimates. An estimate that is particularly susceptible to
significant change in the near-term relates to the determination of
the allowance for loan losses.
Basis of Presentation. In the opinion of management, the
accompanying unaudited consolidated financial statements contain
all adjustments (consisting only of normal recurring adjustments)
necessary for a fair presentation of our financial condition as of
March 31, 2022, and the results of operations, changes in
shareholders’ equity and cash flows for the interim periods
presented. The results of operations for the three months ended
March 31, 2022 are not necessarily indicative of the results of
operations for the year ending December 31, 2022. Certain
information and disclosures normally included in financial
statements prepared in accordance with U.S. GAAP have been omitted
pursuant to the rules and regulations of the Securities and
Exchange Commission.
These
unaudited consolidated financial statements should be read in
conjunction with the audited consolidated financial statements as
of and for the year ended December 31, 2021, included in our Annual
Report on Form 10-K for the year ended December 31, 2021 (the “2021
Annual Report”).
Reclassifications. Amounts in the prior period financial
statements are reclassified when necessary to conform to the
current year presentation.
2.
EARNINGS PER
SHARE
Basic
earnings per share represents income available to common
shareholders divided by the weighted-average number of common
shares outstanding during the period. If rights to dividends on
unvested awards are non-forfeitable, these unvested awards are
considered outstanding in the computation of basic earnings per
share. Diluted earnings per share reflect additional common shares
that would have been outstanding if dilutive potential common
shares had been issued, as well as any adjustment to income that
would result from the assumed issuance. Potential common shares
that may be issued by us relate to stock options and certain
performance-based restricted stock awards and are determined using
the treasury stock method. Unallocated Employee Stock Ownership
Plan (“ESOP”) shares are not deemed outstanding for earnings per
share calculations. There were no anti-dilutive shares outstanding
during the three months ended March 31, 2022 and 2021.
Earnings per common share for the three months ended March 31, 2022
and 2021 have been computed based on the
following:
|
|
|
|
|
|
|
|
|
|
|
Three
Months Ended |
|
|
|
March 31, |
|
|
|
2022 |
|
|
2021 |
|
|
|
(In thousands, except
per share data) |
|
|
|
|
|
|
|
|
Net income applicable to common stock |
|
$ |
5,319 |
|
|
$ |
5,791 |
|
|
|
|
|
|
|
|
|
|
Average
number of common shares issued |
|
|
22,705 |
|
|
|
25,118 |
|
Less:
Average unallocated ESOP Shares |
|
|
(445 |
) |
|
|
(527 |
) |
Less: Average unvested equity incentive plan shares |
|
|
(160 |
) |
|
|
(105 |
) |
|
|
|
|
|
|
|
|
|
Average number of common shares outstanding used to calculate basic
earnings per common share |
|
|
22,100 |
|
|
|
24,486 |
|
Effect of dilutive equity incentive plan |
|
|
41 |
|
|
|
28 |
|
Effect of dilutive stock options |
|
|
32 |
|
|
|
30 |
|
Average number of common shares outstanding used to calculate
diluted earnings per common share |
|
|
22,173 |
|
|
|
24,544 |
|
|
|
|
|
|
|
|
|
|
Basic
earnings per share |
|
$ |
0.24 |
|
|
$ |
0.24 |
|
Diluted
earnings per share |
|
$ |
0.24 |
|
|
$ |
0.24 |
|
|
|
|
|
|
|
|
|
|
3.
COMPREHENSIVE
INCOME (LOSS)
Accounting
principles generally require that recognized revenue, expenses,
gains and losses be included in net income. Although certain
changes in assets and liabilities are reported as a separate
component of the equity section of the balance sheet, such items,
along with net income, are components of comprehensive income
(loss).
The components of accumulated other comprehensive loss included in
shareholders’ equity are as follows:
|
|
March 31, 2022 |
|
|
December 31, 2021 |
|
|
|
(In thousands) |
|
|
|
|
|
|
|
|
Net
unrealized losses on available-for-sale securities |
|
$ |
(16,149 |
) |
|
$ |
(4,685 |
) |
Tax effect |
|
|
4,094 |
|
|
|
1,160 |
|
Net-of-tax amount |
|
|
(12,055 |
) |
|
|
(3,525 |
) |
|
|
|
|
|
|
|
|
|
Unrecognized
actuarial loss on the defined benefit plan |
|
|
(12,067 |
) |
|
|
(12,225 |
) |
Tax effect |
|
|
3,391 |
|
|
|
3,436 |
|
Net-of-tax amount |
|
|
(8,676 |
) |
|
|
(8,789 |
) |
|
|
|
|
|
|
|
|
|
Accumulated other comprehensive loss |
|
$ |
(20,731 |
) |
|
$ |
(12,314 |
) |
4. INVESTMENT
SECURITIES
Available-for-sale and held-to-maturity investment securities at
March 31, 2022 and December 31, 2021 are summarized as
follows:
|
|
March 31, 2022 |
|
|
|
Amortized Cost |
|
|
Gross
Unrealized
Gains |
|
|
Gross
Unrealized
Losses |
|
|
Fair Value |
|
|
|
(In thousands) |
|
Available-for-sale securities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt securities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Government-sponsored enterprise obligations |
|
$ |
|
|
$ |
|
|
$ |
) |
|
$ |
|
State and municipal bonds |
|
|
405 |
|
|
|
1 |
|
|
|
— |
|
|
|
406 |
|
Corporate bonds |
|
|
3,022 |
|
|
|
— |
|
|
|
(26 |
) |
|
|
2,996 |
|
Total debt securities |
|
|
18,331 |
|
|
|
1 |
|
|
|
(1,784 |
) |
|
|
16,548 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mortgage-backed securities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Government-sponsored mortgage-backed securities |
|
|
|
|
|
|
|
|
) |
|
|
|
U.S. government guaranteed mortgage-backed securities |
|
|
8,580 |
|
|
|
— |
|
|
|
(916 |
) |
|
|
7,664 |
|
Total mortgage-backed securities |
|
|
171,728 |
|
|
|
39 |
|
|
|
(14,405 |
) |
|
|
157,362 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total available-for-sale |
|
|
190,059 |
|
|
|
40 |
|
|
|
(16,189 |
) |
|
|
173,910 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Held-to-maturity securities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt securities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. Treasury securities |
|
|
9,981 |
|
|
|
— |
|
|
|
(461 |
) |
|
|
9,520 |
|
Total debt securities |
|
|
9,981 |
|
|
|
— |
|
|
|
(461 |
) |
|
|
9,520 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mortgage-backed securities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Government-sponsored mortgage-backed securities |
|
|
|
|
|
— |
|
|
|
) |
|
|
|
Total mortgage-backed securities |
|
|
227,594 |
|
|
|
— |
|
|
|
(16,835 |
) |
|
|
210,759 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total held-to-maturity |
|
|
237,575 |
|
|
|
— |
|
|
|
(17,296 |
) |
|
|
220,279 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$ |
427,634 |
|
|
$ |
40 |
|
|
$ |
(33,485 |
) |
|
$ |
394,189 |
|
|
|
December 31, 2021 |
|
|
|
Amortized Cost |
|
|
Gross
Unrealized
Gains |
|
|
Gross
Unrealized
Losses |
|
|
Fair Value |
|
|
|
(In thousands) |
|
Available-for-sale securities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt securities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Government-sponsored enterprise obligations |
|
$ |
|
|
$ |
|
|
$ |
) |
|
$ |
|
State and municipal bonds |
|
|
405 |
|
|
|
1 |
|
|
|
— |
|
|
|
406 |
|
Corporate bonds |
|
|
3,026 |
|
|
|
86 |
|
|
|
— |
|
|
|
3,112 |
|
Total debt securities |
|
|
18,333 |
|
|
|
87 |
|
|
|
(676 |
) |
|
|
17,744 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mortgage-backed securities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Government-sponsored mortgage-backed securities |
|
|
|
|
|
|
|
|
) |
|
|
|
U.S. government guaranteed mortgage-backed securities |
|
|
9,693 |
|
|
|
8 |
|
|
|
(602 |
) |
|
|
9,099 |
|
Total mortgage-backed securities |
|
|
180,704 |
|
|
|
435 |
|
|
|
(4,531 |
) |
|
|
176,608 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total available-for-sale |
|
|
199,037 |
|
|
|
522 |
|
|
|
(5,207 |
) |
|
|
194,352 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Held-to-maturity securities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt securities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. Treasury securities |
|
|
9,979 |
|
|
|
— |
|
|
|
(6 |
) |
|
|
9,973 |
|
Total debt securities |
|
|
9,979 |
|
|
|
— |
|
|
|
(6 |
) |
|
|
9,973 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mortgage-backed securities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Government-sponsored mortgage-backed securities |
|
|
|
|
|
— |
|
|
|
) |
|
|
|
Total mortgage-backed securities |
|
|
212,293 |
|
|
|
— |
|
|
|
(2,518 |
) |
|
|
209,775 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total held-to-maturity |
|
|
222,272 |
|
|
|
— |
|
|
|
(2,524 |
) |
|
|
219,748 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$ |
421,309 |
|
|
$ |
522 |
|
|
$ |
(7,731 |
) |
|
$ |
414,100 |
|
At
March 31, 2022, U.S. Treasury securities with a fair value of
$4.7
million, government-sponsored enterprise obligations with a fair
value of $
million and mortgage-backed securities with a fair value of
$55.4
million were pledged to secure public deposits and for other
purposes as required or permitted by law. The securities
collateralizing public deposits are subject to fluctuations in fair
value. We monitor the fair value of the collateral on a periodic
basis, and pledge additional collateral if necessary based on
changes in fair value of collateral or the balances of such
deposits.
The amortized cost and fair value of available-for-sale and
held-to-maturity securities at March 31, 2022, by final maturity,
are shown below. Actual maturities may differ from
contractual maturities because certain issuers have the right to
call or prepay obligations.
|
|
Available-for-Sale |
|
|
Held-to-Maturity |
|
|
|
Amortized Cost |
|
|
Fair Value |
|
|
Amortized Cost |
|
|
Fair Value |
|
|
|
(In thousands) |
|
Debt securities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Due after one year through five years |
|
$ |
3,427 |
|
|
$ |
3,402 |
|
|
$ |
9,981 |
|
|
$ |
9,520 |
|
Due
after five years through ten years |
|
|
9,904 |
|
|
|
8,869 |
|
|
|
— |
|
|
|
— |
|
Due after ten years |
|
|
5,000 |
|
|
|
4,277 |
|
|
|
— |
|
|
|
— |
|
Total debt securities |
|
|
18,331 |
|
|
|
16,548 |
|
|
|
9,981 |
|
|
|
9,520 |
|
Mortgage-backed securities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Due
after five years through ten years |
|
|
1,901 |
|
|
|
1,823 |
|
|
|
— |
|
|
|
— |
|
Due after ten years |
|
|
169,827 |
|
|
|
155,539 |
|
|
|
227,594 |
|
|
|
210,759 |
|
Total
mortgage-backed securities |
|
|
171,728 |
|
|
|
157,362 |
|
|
|
227,594 |
|
|
|
210,759 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total securities |
|
$ |
190,059 |
|
|
$ |
173,910 |
|
|
$ |
237,575 |
|
|
$ |
220,279 |
|
Gross realized gains and losses on sales of available-for-sale
securities for the three months ended March 31, 2022 and 2021 are
as follows:
|
|
|
|
|
|
|
|
|
|
|
Three
Months Ended |
|
|
|
March 31, |
|
|
|
2022 |
|
|
2021 |
|
|
|
(In thousands) |
|
|
|
|
|
|
|
|
Gross gains realized |
|
$ |
— |
|
|
$ |
— |
|
Gross
losses realized |
|
|
(4 |
) |
|
|
(62 |
) |
Net loss
realized |
|
$ |
(4 |
) |
|
$ |
(62 |
) |
Proceeds
from the sales and redemption of available-for-sale securities
totaled $20,000
and $14,000
for the three months ended March 31, 2022 and 2021,
respectively.
Information pertaining to securities with gross unrealized losses
at March 31, 2022 and December 31, 2021, aggregated by investment
category and length of time that individual securities have been in
a continuous loss position are as follows:
|
|
March 31, 2022 |
|
|
|
Less Than Twelve Months |
|
|
Over Twelve Months |
|
|
|
Number of Securities |
|
|
Fair Value |
|
|
Gross Unrealized Loss |
|
|
Depreciation from Amortized Cost
Basis (%) |
|
|
Number of Securities |
|
|
Fair Value |
|
|
Gross Unrealized Loss |
|
|
Depreciation from Amortized Cost
Basis (%) |
|
|
|
(Dollars in thousands) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Available-for-sale: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Government-sponsored mortgage-backed
securities |
|
|
|
|
$ |
|
|
$ |
|
|
|
% |
|
|
|
|
$ |
|
|
$ |
|
|
|
% |
U.S. government guaranteed
mortgage-backed securities |
|
|
2 |
|
|
|
1,093 |
|
|
|
55 |
|
|
|
4.8 |
|
|
|
7 |
|
|
|
6,571 |
|
|
|
861 |
|
|
|
11.6 |
|
Government-sponsored enterprise
obligations |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate Bonds |
|
|
1 |
|
|
|
2,996 |
|
|
|
26 |
|
|
|
0.9 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
|
|
Total available-for-sale |
|
|
42 |
|
|
|
78,986 |
|
|
|
5,958 |
|
|
|
|
|
|
|
37 |
|
|
|
90,507 |
|
|
|
10,231 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Held-to-maturity: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. Treasury securities |
|
|
2 |
|
|
|
9,520 |
|
|
|
461 |
|
|
|
4.6 |
% |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
% |
Government-sponsored mortgage-backed
securities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total held-to-maturity |
|
|
35 |
|
|
|
207,766 |
|
|
|
15,984 |
|
|
|
|
|
|
|
2 |
|
|
|
12,513 |
|
|
|
1,312 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
|
77 |
|
|
$ |
286,752 |
|
|
$ |
21,942 |
|
|
|
|
|
|
|
39 |
|
|
$ |
103,020 |
|
|
$ |
11,543 |
|
|
|
|
|
|
|
December 31, 2021 |
|
|
|
Less Than Twelve Months |
|
|
Over Twelve Months |
|
|
|
Number of Securities |
|
|
Fair Value |
|
|
Gross Unrealized Loss |
|
|
Depreciation from Amortized Cost Basis (%) |
|
|
Number of Securities |
|
|
Fair Value |
|
|
Gross Unrealized Loss |
|
|
Depreciation from Amortized Cost Basis (%) |
|
|
|
(Dollars in
thousands) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Available-for-sale: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Government-sponsored mortgage-backed securities |
|
|
|
|
$ |
|
|
$ |
|
|
|
% |
|
|
|
|
$ |
|
|
$ |
|
|
|
% |
U.S. government guaranteed mortgage-backed securities |
|
|
2 |
|
|
|
2,426 |
|
|
|
142 |
|
|
|
5.5 |
|
|
|
5 |
|
|
|
5,107 |
|
|
|
460 |
|
|
|
8.3 |
|
Government-sponsored enterprise obligations |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total available-for-sale |
|
|
36 |
|
|
|
107,647 |
|
|
|
2,230 |
|
|
|
|
|
|
|
26 |
|
|
|
61,839 |
|
|
|
2,977 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Held-to-maturity: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. Treasury securities |
|
|
2 |
|
|
|
9,973 |
|
|
|
6 |
|
|
|
0.1 |
% |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
% |
Government-sponsored mortgage-backed securities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total held-to-maturity |
|
|
33 |
|
|
|
219,748 |
|
|
|
2,524 |
|
|
|
|
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
|
69 |
|
|
$ |
327,395 |
|
|
$ |
4,754 |
|
|
|
|
|
|
|
26 |
|
|
$ |
61,839 |
|
|
$ |
2,977 |
|
|
|
|
|
During
the three months ended March 31, 2022 and year ended December 31,
2021, the Company did not record any other-than-temporary
impairment (“OTTI”) charges on its investments. Management
regularly reviews the portfolio for securities with unrealized
losses. Management attributed the unrealized losses at March 31,
2022 to increases in current market yields compared to the yields
at the time the investments were purchased by the Company and not
due to credit quality.
The
process for assessing investments for OTTI may vary depending on
the type of security. In assessing the Company's investments in
government-sponsored and U.S. government guaranteed mortgage-backed
securities and government-sponsored enterprise obligations, the
contractual cash flows of these investments are guaranteed by the
respective government-sponsored enterprise; Federal Home Loan
Mortgage Corporation (“FHLMC”), Federal National Mortgage
Association (“FNMA”), Federal Farm Credit Bank (“FFCB”), or Federal
Home Loan Bank (“FHLB”). Accordingly, it is expected that the
securities would not be settled at a price less than the par value
of the Company's investments. Management's assessment of other debt
securities within the portfolio includes reviews of market pricing,
ongoing credit quality evaluations, assessment of the investments'
materiality, and duration of the investments' unrealized loss
position. At March 31, 2022, the Company's corporate and municipal
bond portfolios did not contain any securities rated below
investment grade, as reported by major credit rating
agencies.
5.
LOANS AND
ALLOWANCE FOR LOAN LOSSES
Major classifications of loans at the periods indicated were as
follows:
|
|
March 31, |
|
|
December 31, |
|
|
|
2022 |
|
|
2021 |
|
|
|
(In thousands) |
|
Commercial real estate |
|
$ |
1,039,487 |
|
|
$ |
979,969 |
|
Residential real estate: |
|
|
|
|
|
|
|
|
Residential one-to-four family |
|
|
564,339 |
|
|
|
552,332 |
|
Home equity |
|
|
100,165 |
|
|
|
99,759 |
|
Total residential real estate |
|
|
664,504 |
|
|
|
652,091 |
|
|
|
|
|
|
|
|
|
|
Commercial and industrial: |
|
|
|
|
|
|
|
|
Paycheck Protection Program (“PPP”) loans |
|
|
6,052 |
|
|
|
25,329 |
|
Commercial and industrial |
|
|
209,890 |
|
|
|
201,340 |
|
Total commercial and industrial |
|
|
215,942 |
|
|
|
226,669 |
|
|
|
|
|
|
|
|
|
|
Consumer |
|
|
4,252 |
|
|
|
4,250 |
|
Total gross loans |
|
|
1,924,185 |
|
|
|
1,862,979 |
|
Unamortized PPP
loan fees |
|
|
(255 |
) |
|
|
(781 |
) |
Unearned premiums and deferred loan fees and costs, net |
|
|
2,355 |
|
|
|
2,518 |
|
Total loans, net |
|
|
1,926,285 |
|
|
|
1,864,716 |
|
Allowance for loan losses |
|
|
(19,308 |
) |
|
|
(19,787 |
) |
Net loans |
|
$ |
1,906,977 |
|
|
$ |
1,844,929 |
|
Loans
Serviced for Others.
The
Company has transferred a portion of its originated commercial
loans to participating lenders. The amounts transferred have been
accounted for as sales and are therefore not included in our
accompanying consolidated balance sheets. We continue to service
the loans on behalf of the participating lenders. We share with
participating lenders, on a pro-rata basis, any gains or losses
that may result from a borrower’s lack of compliance with
contractual terms of the loan. At March 31, 2022 and December 31,
2021, the Company was servicing commercial loans participated out
to various other institutions totaling $78.3
million and $63.2
million, respectively.
Residential
real estate mortgages are originated by the Bank both for its
portfolio and for sale into the secondary market. The Bank may sell
its loans to institutional investors such as the FHLMC. Under loan
sale and servicing agreements with the investor, the Bank generally
continues to service the residential real estate mortgages. The
Bank pays the investor an agreed upon rate on the loan, which is
less than the interest rate received from the borrower. The Bank
retains the difference as a fee for servicing the residential real
estate mortgages. The Bank capitalizes mortgage servicing rights at
their fair value upon sale of the related loans, amortizes the
asset over the estimated life of the serviced loan, and
periodically assesses the asset for impairment. The significant
assumptions used by a third party to estimate the fair value of
capitalized servicing rights at March 31, 2022, include weighted
average prepayment speed for the portfolio using the Public
Securities Association Standard Prepayment Model (122 PSA),
weighted average internal rate of return (9.02%),
weighted average servicing fee (0.25%),
and average cost to service loans ($83.63 per loan). The
estimated fair value of capitalized servicing rights may vary
significantly in subsequent periods primarily due to changing
market interest rates, and their effect on prepayment speeds and
discount rates. For the three months ended March 31, 2022 and 2021,
the Company sold $277,000
and $7.6
million in residential real estate mortgages with servicing
retained and recorded gains on the sale of mortgages of $2,000 and $227,000,
respectively, within non-interest income.
At
March 31, 2022 and December 31, 2021, the Company was servicing
residential mortgage loans owned by investors totaling $85.5 million and
$88.2 million,
respectively. Servicing fee income of $53,000 and $24,000
was recorded for the three months ended March 31, 2022 and 2021,
respectively, and is included in service charges and fees on the
consolidated statements of net income.
A summary of the activity in the balances of mortgage servicing
rights follows:
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, |
|
|
|
2022 |
|
|
2021 |
|
|
|
(In thousands) |
|
|
|
|
|
|
|
|
Balance at the beginning of year: |
|
$ |
693 |
|
|
$ |
153 |
|
Capitalized mortgage servicing rights |
|
|
2 |
|
|
|
48 |
|
Amortization |
|
|
(36 |
) |
|
|
(15 |
) |
Balance at the end of period |
|
$ |
659 |
|
|
$ |
186 |
|
Fair value at the end of period |
|
$ |
813 |
|
|
$ |
235 |
|
Loans
are recorded at the principal amount outstanding, adjusted for
charge-offs, unearned premiums and deferred loan fees and costs.
Interest on loans is calculated using the effective yield method on
daily balances of the principal amount outstanding and is credited
to income on the accrual basis to the extent it is deemed
collectable. Our general policy is to discontinue the accrual of
interest when principal or interest payments are delinquent 90 days
or more based on the contractual terms of the loan, or earlier if
the loan is considered impaired. Any unpaid amounts previously
accrued on these loans are reversed from income. Subsequent cash
receipts are applied to the outstanding principal balance or to
interest income if, in the judgment of management, collection of
the principal balance is not in question. Loans are returned to
accrual status when they become current as to both principal and
interest and perform in accordance with contractual terms for a
period of at least six months, reducing the concern as to the
collectability of principal and interest. Loan fees and certain
direct loan origination costs are deferred, and the net fee or cost
is recognized as an adjustment to interest income over the
estimated average lives of the related loans.
The
allowance for loan losses is established through provisions for
loan losses charged to expense. Loans are charged-off against the
allowance when management believes that the collectability of the
principal is unlikely. Subsequent recoveries, if any, are credited
to the allowance.
The
allowance for loan losses is evaluated on a regular basis by
management. This evaluation is inherently subjective as it requires
estimates that are susceptible to significant revision as more
information becomes available. The allowance consists of general,
allocated, and unallocated components, as further described
below.
General component
The
general component of the allowance for loan losses is based on
historical loss experience adjusted for qualitative factors
stratified by the following loan segments: residential real estate
(includes one-to-four family and home equity), commercial real
estate, commercial and industrial, and consumer. Management uses a
rolling average of historical losses based on a time frame
appropriate to capture relevant loss data for each loan segment.
This historical loss factor is adjusted for the following
qualitative factors: trends in delinquencies and nonperforming
loans; trends in volume and terms of loans; effects of changes in
risk selection and underwriting standards and other changes in
lending policies, procedures and practices; and national and local
economic trends and industry conditions. There were no changes to
the Company’s policies and procedures surrounding the allowance for
loan losses during the three months ended March 31, 2022. In
addition, during the year ended December 31, 2020, the Company
determined that it was prudent to provide an allowance for loan
losses related to the loan portfolio acquired on October 24, 2016
from Chicopee Bancorp, Inc. (“Chicopee”) due to the ongoing impacts
and extended nature of the pandemic.
The
qualitative factors are determined based on the various risk
characteristics of each loan segment. Risk characteristics relevant
to each portfolio segment are as follows:
Residential
real estate. We require private mortgage insurance for all
loans originated with a loan-to-value ratio greater than 80%
and we do not grant subprime loans. All loans in this segment are
collateralized by owner-occupied residential real estate and
repayment is dependent on the credit quality of the individual
borrower. Home equity loans are secured by first or second
mortgages on one-to-four family owner occupied properties. The
overall health of the economy, including unemployment rates and
housing prices, will have an effect on the credit quality in this
segment.
Commercial
real estate. Loans in this segment are primarily
income-producing investment properties and owner-occupied
commercial properties throughout New England. The underlying cash
flows generated by the properties or operations can be adversely
impacted by a downturn in the economy due to increased vacancy
rates or diminished cash flows, which in turn, would have an effect
on the credit quality in this segment. Management obtains financial
information annually and continually monitors the cash flows of
these loans.
Commercial
and industrial loans. Loans in this segment are made to
businesses and are generally secured by assets of the business.
Repayment is expected from the cash flows of the business. A
weakened economy, and resultant decreased consumer spending, will
have an effect on the credit quality in this segment.
Consumer
loans. Loans in this segment are secured or unsecured and
repayment is dependent on the credit quality of the individual
borrower.
Allocated component
The
allocated component relates to loans that are classified as
impaired. Impaired loans are identified by analysis of loan
performance, internal credit ratings and watch list loans that
management believes are subject to a higher risk of loss.
Impairment is measured on a loan by loan basis for commercial real
estate and commercial and industrial loans by either the present
value of expected future cash flows discounted at the loan’s
effective interest rate or the fair value of the collateral if the
loan is collateral dependent. An allowance is established when the
discounted cash flows (or collateral value) of the impaired loan is
lower than the carrying value of that loan. Large groups of smaller
balance homogeneous loans are collectively evaluated for
impairment. Accordingly, we do not separately identify individual
consumer and residential real estate loans for impairment
disclosures, unless such loans are subject to a troubled debt
restructuring agreement.
A
loan is considered impaired when, based on current information and
events, it is probable that we will be unable to collect the
scheduled payments of principal or interest when due according to
the contractual terms of the loan agreement. Factors considered by
management in determining impairment include payment status,
collateral value, and the probability of collecting scheduled
principal and interest payments when due. Loans that experience
insignificant payment delays and payment shortfalls generally are
not classified as impaired. We determine the significance of
payment delays and payment shortfalls on a case-by-case basis,
taking into consideration all of the circumstances surrounding the
loan and the borrower, including the length of the delay, the
reasons for the delay, the borrower’s prior payment record, and the
amount of the shortfall in relation to the principal and interest
owed.
Unallocated component
An
unallocated component may be maintained to cover uncertainties that
could affect management’s estimate of probable losses. The
unallocated component of the allowance, if any, reflects the margin
of imprecision inherent in the underlying assumptions used in the
methodologies for estimating allocated and general reserves in the
portfolio.
An analysis of changes in the allowance for loan losses by segment
for the three months ended March 31, 2022 and 2021 is as
follows:
|
|
Commercial Real Estate |
|
|
Residential Real Estate |
|
|
Commercial and Industrial |
|
|
Consumer |
|
|
Unallocated |
|
|
Total |
|
|
|
(In thousands) |
|
Balance at December 31, 2020 |
|
$ |
13,020 |
|
|
$ |
4,240 |
|
|
$ |
3,630 |
|
|
$ |
241 |
|
|
$ |
26 |
|
|
$ |
21,157 |
|
Provision (credit) |
|
|
295 |
|
|
|
(135 |
) |
|
|
(60 |
) |
|
|
(13 |
) |
|
|
(12 |
) |
|
|
75 |
|
Charge-offs |
|
|
— |
|
|
|
— |
|
|
|
(9 |
) |
|
|
(24 |
) |
|
|
— |
|
|
|
(33 |
) |
Recoveries |
|
|
— |
|
|
|
8 |
|
|
|
1 |
|
|
|
19 |
|
|
|
— |
|
|
|
28 |
|
Balance at March 31, 2021 |
|
$ |
13,315 |
|
|
$ |
4,113 |
|
|
$ |
3,562 |
|
|
$ |
223 |
|
|
$ |
14 |
|
|
$ |
21,227 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at December 31, 2021 |
|
$ |
12,970 |
|
|
$ |
3,964 |
|
|
$ |
2,643 |
|
|
$ |
197 |
|
|
$ |
13 |
|
|
$ |
19,787 |
|
Provision (credit) |
|
|
(639 |
) |
|
|
90 |
|
|
|
89 |
|
|
|
27 |
|
|
|
8 |
|
|
|
(425 |
) |
Charge-offs |
|
|
(37 |
) |
|
|
(16 |
) |
|
|
(7 |
) |
|
|
(45 |
) |
|
|
— |
|
|
|
(105 |
) |
Recoveries |
|
|
— |
|
|
|
30 |
|
|
|
1 |
|
|
|
20 |
|
|
|
— |
|
|
|
51 |
|
Balance at March 31, 2022 |
|
$ |
12,294 |
|
|
$ |
4,068 |
|
|
$ |
2,726 |
|
|
$ |
199 |
|
|
$ |
21 |
|
|
$ |
19,308 |
|
The following table presents information pertaining to the
allowance for loan losses by segment, excluding PPP loans, for the
dates indicated:
|
|
Commercial Real Estate |
|
|
Residential Real Estate |
|
|
Commercial and Industrial |
|
|
Consumer |
|
|
Unallocated |
|
|
Total |
|
|
|
(In thousands) |
|
March 31, 2022 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amount of
allowance for impaired loans |
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
Amount of allowance for non-impaired loans |
|
|
12,294 |
|
|
|
4,068 |
|
|
|
2,726 |
|
|
|
199 |
|
|
|
21 |
|
|
|
19,308 |
|
Total allowance for loan losses |
|
$ |
12,294 |
|
|
$ |
4,068 |
|
|
$ |
2,726 |
|
|
$ |
199 |
|
|
$ |
21 |
|
|
$ |
19,308 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Impaired loans |
|
$ |
9,527 |
|
|
$ |
2,976 |
|
|
$ |
620 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
13,123 |
|
Non-impaired loans |
|
|
1,025,725 |
|
|
|
659,784 |
|
|
|
208,907 |
|
|
|
4,252 |
|
|
|
— |
|
|
|
1,898,668 |
|
Impaired loans acquired with deteriorated credit quality |
|
|
4,235 |
|
|
|
1,744 |
|
|
|
363 |
|
|
|
— |
|
|
|
— |
|
|
|
6,342 |
|
Total loans |
|
$ |
1,039,487 |
|
|
$ |
664,504 |
|
|
$ |
209,890 |
|
|
$ |
4,252 |
|
|
$ |
— |
|
|
$ |
1,918,133 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2021 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amount of allowance for impaired loans |
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
Amount of allowance for non-impaired loans |
|
|
12,970 |
|
|
|
3,964 |
|
|
|
2,643 |
|
|
|
197 |
|
|
|
13 |
|
|
|
19,787 |
|
Total allowance for loan losses |
|
$ |
12,970 |
|
|
$ |
3,964 |
|
|
$ |
2,643 |
|
|
$ |
197 |
|
|
$ |
13 |
|
|
$ |
19,787 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Impaired loans |
|
$ |
9,601 |
|
|
$ |
3,223 |
|
|
$ |
699 |
|
|
$ |
22 |
|
|
$ |
— |
|
|
$ |
13,545 |
|
Non-impaired loans |
|
|
965,577 |
|
|
|
647,098 |
|
|
|
200,271 |
|
|
|
4,228 |
|
|
|
— |
|
|
|
1,817,174 |
|
Impaired loans acquired with deteriorated credit quality |
|
|
4,791 |
|
|
|
1,770 |
|
|
|
370 |
|
|
|
— |
|
|
|
— |
|
|
|
6,931 |
|
Total loans |
|
$ |
979,969 |
|
|
$ |
652,091 |
|
|
$ |
201,340 |
|
|
$ |
4,250 |
|
|
$ |
— |
|
|
$ |
1,837,650 |
|
Past
Due and Nonaccrual Loans.
The following tables present an age analysis of past due loans,
excluding PPP loans, as of the dates indicated:
|
|
30 – 59 Days Past Due |
|
|
60 – 89 Days Past Due |
|
|
90 Days or More Past Due |
|
|
Total
Past
Due Loans
|
|
|
Total
Current
Loans
|
|
|
Total
Loans
|
|
|
Nonaccrual Loans |
|
|
|
(In thousands) |
|
March 31, 2022 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Commercial real estate |
|
$ |
301 |
|
|
$ |
— |
|
|
$ |
436 |
|
|
$ |
737 |
|
|
$ |
1,038,750 |
|
|
$ |
1,039,487 |
|
|
$ |
660 |
|
Residential real estate: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Residential |
|
|
561 |
|
|
|
270 |
|
|
|
853 |
|
|
|
1,684 |
|
|
|
562,655 |
|
|
|
564,339 |
|
|
|
2,846 |
|
Home equity |
|
|
230 |
|
|
|
— |
|
|
|
88 |
|
|
|
318 |
|
|
|
99,847 |
|
|
|
100,165 |
|
|
|
112 |
|
Commercial and industrial |
|
|
42 |
|
|
|
— |
|
|
|
24 |
|
|
|
66 |
|
|
|
209,824 |
|
|
|
209,890 |
|
|
|
370 |
|
Consumer |
|
|
3 |
|
|
|
— |
|
|
|
— |
|
|
|
3 |
|
|
|
4,249 |
|
|
|
4,252 |
|
|
|
— |
|
Total
loans
|
|
$ |
1,137 |
|
|
$ |
270 |
|
|
$ |
1,401 |
|
|
$ |
2,808 |
|
|
$ |
1,915,325 |
|
|
$ |
1,918,133 |
|
|
$ |
3,988 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2021 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Commercial real estate |
|
$ |
139 |
|
|
$ |
— |
|
|
$ |
436 |
|
|
$ |
575 |
|
|
$ |
979,394 |
|
|
$ |
979,969 |
|
|
$ |
1,224 |
|
Residential real estate: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Residential |
|
|
787 |
|
|
|
41 |
|
|
|
507 |
|
|
|
1,335 |
|
|
|
550,997 |
|
|
|
552,332 |
|
|
|
3,214 |
|
Home equity |
|
|
57 |
|
|
|
5 |
|
|
|
63 |
|
|
|
125 |
|
|
|
99,634 |
|
|
|
99,759 |
|
|
|
94 |
|
Commercial and industrial |
|
|
58 |
|
|
|
10 |
|
|
|
22 |
|
|
|
90 |
|
|
|
201,250 |
|
|
|
201,340 |
|
|
|
410 |
|
Consumer |
|
|
5 |
|
|
|
— |
|
|
|
11 |
|
|
|
16 |
|
|
|
4,234 |
|
|
|
4,250 |
|
|
|
22 |
|
Total loans |
|
$ |
1,046 |
|
|
$ |
56 |
|
|
$ |
1,039 |
|
|
$ |
2,141 |
|
|
$ |
1,835,509 |
|
|
$ |
1,837,650 |
|
|
$ |
4,964 |
|
Impaired
Loans.
The following is a summary of impaired loans by
class:
|
|
|
|
|
|
|
|
|
|
|
Three
Months Ended |
|
|
|
At March 31, 2022 |
|
|
March 31, 2022 |
|
|
|
Recorded Investment |
|
|
Unpaid Principal Balance |
|
|
Related Allowance |
|
|
Average Recorded Investment |
|
|
Interest Income Recognized |
|
|
|
(In thousands) |
|
Impaired
Loans (1) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Commercial real estate |
|
$ |
13,762 |
|
|
$ |
14,907 |
|
|
$ |
— |
|
|
$ |
14,078 |
|
|
$ |
53 |
|
Residential real estate: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Residential real estate |
|
|
4,590 |
|
|
|
5,422 |
|
|
|
— |
|
|
|
4,735 |
|
|
|
16 |
|
Home equity |
|
|
130 |
|
|
|
153 |
|
|
|
— |
|
|
|
121 |
|
|
|
1 |
|
Commercial and industrial |
|
|
983 |
|
|
|
3,748 |
|
|
|
— |
|
|
|
1,026 |
|
|
|
15 |
|
Consumer |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
11 |
|
|
|
— |
|
Total impaired loans |
|
$ |
19,465 |
|
|
$ |
24,230 |
|
|
$ |
— |
|
|
$ |
19,971 |
|
|
$ |
85 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three
Months Ended |
|
|
|
At December 31, 2021 |
|
|
March 31, 2021 |
|
|
|
Recorded Investment |
|
|
Unpaid Principal Balance |
|
|
Related Allowance |
|
|
Average Recorded Investment |
|
|
Interest Income Recognized |
|
|
|
(In thousands) |
|
Impaired
Loans (1) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Commercial real estate |
|
$ |
14,392 |
|
|
$ |
15,563 |
|
|
$ |
— |
|
|
$ |
17,403 |
|
|
$ |
108 |
|
Residential rea estate: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Residential real estate |
|
|
4,881 |
|
|
|
5,381 |
|
|
|
— |
|
|
|
6,357 |
|
|
|
104 |
|
Home equity |
|
|
112 |
|
|
|
136 |
|
|
|
— |
|
|
|
143 |
|
|
|
4 |
|
Commercial and industrial |
|
|
1,069 |
|
|
|
3,850 |
|
|
|
— |
|
|
|
4,827 |
|
|
|
62 |
|
Consumer |
|
|
22 |
|
|
|
37 |
|
|
|
— |
|
|
|
26 |
|
|
|
— |
|
Total impaired loans |
|
$ |
20,476 |
|
|
$ |
24,967 |
|
|
$ |
— |
|
|
$ |
28,756 |
|
|
$ |
278 |
|
(1) |
|
Includes
loans acquired with deteriorated credit quality and performing
troubled debt restructurings. |
With
the exception of loans acquired with deteriorated credit quality,
the majority of impaired loans are included within the nonaccrual
balances; however, not every loan on nonaccrual status has been
designated as impaired. Impaired loans include loans that have been
modified in a troubled debt restructuring (“TDR”). Impaired loans
are individually evaluated and exclude large groups of
smaller-balance homogeneous loans, such as residential mortgage
loans and consumer loans, which are collectively evaluated for
impairment, and loans that are measured at fair value, unless the
loan is amended in a TDR.
All
payments received on impaired loans in nonaccrual status are
applied to principal. There was no interest income recognized on
nonaccrual impaired loans during the three months ended March 31,
2022 and March 31, 2021. The Company's obligation to fulfill the
additional funding commitments on impaired loans is generally
contingent on the borrower's compliance with the terms of the
credit agreement. If the borrower is not in compliance, additional
funding commitments may or may not be made at the Company's
discretion. At March 31, 2022 and 2021, we had not committed to
lend any additional funds for loans that are classified as
impaired. Payments received on impaired loans in accrual status are
recorded in accordance with the contractual terms of the loan.
Interest income recognized on impaired loans during the three
months ended March 31, 2022 and 2021 pertained to performing TDRs
and purchased impaired loans.
Troubled
Debt Restructurings.
Loans
are designated as a TDR when, as part of an agreement to modify the
original contractual terms of the loan as a result of financial
difficulties of the borrower, the Bank grants the borrower a
concession on the terms that would not otherwise be considered.
Typically, such concessions may consist of a reduction in interest
rate to a below market rate, taking into account the credit quality
of the note, extension of additional credit based on receipt of
adequate collateral, or a deferment or reduction of payments
(principal or interest) which materially alters the Bank's position
or significantly extends the note's maturity date, such that the
present value of cash flows to be received is materially less than
those contractually established at the loan's origination. All
loans that are modified are reviewed by the Company to identify if
a TDR has occurred. All TDR loans are classified as
impaired.
When
we modify loans in a TDR, we measure impairment similar to other
impaired loans based on the present value of expected future cash
flows, discounted at the contractual interest rate of the original
loan agreement, or use the current fair value of the collateral,
less selling costs for collateral dependent loans. If we determine
that the value of the modified loan is less than the recorded
investment in the loan (net of previous charge-offs, deferred loan
fees or costs and unamortized premium or discount), impairment is
recognized through a specific allowance or a charge-off to the
allowance. Nonperforming TDRs are included in nonperforming
loans.
There
were no loan modifications classified as TDRs during the three
months ended March 31, 2022 and 2021. During the three months ended
March 31, 2022 and 2021, no TDRs defaulted (defined as 30 days or
more past due) within 12 months of restructuring. There were no
charge-offs on TDRs during the three months ended March 31, 2022 or
2021.
Loans
Acquired with Deteriorated Credit Quality.
The following is a summary of loans acquired with deteriorated
credit quality in the Chicopee acquisition.
|
|
|
Contractual Required Payments Receivable |
|
|
Cash Expected To Be Collected |
|
|
Non- Accretable Discount |
|
|
Accretable Yield |
|
|
Loans Receivable |
|
|
|
|
(In thousands) |
|
Balance
at December 31, 2021 |
|
|
$ |
12,134 |
|
|
$ |
9,430 |
|
|
$ |
2,704 |
|
|
$ |
2,499 |
|
|
$ |
6,931 |
|
Collections |
|
|
|
(669 |
) |
|
|
(639 |
) |
|
|
(30 |
) |
|
|
(50 |
) |
|
|
(589 |
) |
Dispositions |
|
|
|
(58 |
) |
|
|
(58 |
) |
|
|
— |
|
|
|
(58 |
) |
|
|
— |
|
Balance
at March 31, 2022 |
|
|
$ |
11,407 |
|
|
$ |
8,733 |
|
|
$ |
2,674 |
|
|
$ |
2,391 |
|
|
$ |
6,342 |
|
Credit
Quality Information.
The
Company utilizes an eight-grade internal loan rating system for
commercial real estate and commercial and industrial loans.
Performing residential real estate, home equity and consumer loans
are grouped with “Pass” rated loans. Nonperforming residential real
estate, home equity and consumer loans are monitored individually
for impairment and risk rated as “substandard.”
Loans
rated 1 – 4: Loans rated 1-4 represent groups of loans that are
not subject to adverse criticism as defined in regulatory guidance.
Loans in these groups exhibit characteristics that represent
acceptable risk.
Loans
rated 5: Loans rated 5 are considered “Special Mention”
and may exhibit potential credit weaknesses or downward trends and
are being monitored by management. Loans in this category are
currently protected based on collateral and repayment capacity and
do not constitute undesirable credit risk, but have potential
weakness that may result in deterioration of the repayment process
at some future date. This classification is used if a negative
trend is evident in the obligor’s financial situation. Special
mention loans do not sufficiently expose the Company to warrant
adverse classification.
Loans
rated 6: Loans rated 6 are considered “Substandard.” A
loan is classified as substandard if the borrower exhibits a
well-defined weakness and may be inadequately protected by the
current net worth and cash flow capacity to pay the current
debt.
Loans
rated 7: Loans rated 7 are considered “Doubtful.” Loans
classified as doubtful have all the weaknesses inherent in those
classified substandard with the added characteristic that the
weaknesses make collection or liquidation of the loan highly
questionable and improbable. The possibility of some loss is
extremely high, but because of specific pending factors that may
work to the advantage and strengthening of the asset, its
classification as an estimated loss is deferred until its more
exact status may be determined.
Loans
rated 8: Loans rated 8 are considered uncollectible. The loss
classification does not mean that the asset has absolutely no
recovery or salvage value, but rather that it is not practical or
desirable to defer writing off the asset because recovery and
collection time may be affected in the future.
On an
annual basis, or more often if needed, we formally review the
ratings on all commercial real estate and commercial and industrial
loans. In addition, management utilizes delinquency reports, the
criticized loan report and other loan reports to monitor credit
quality. In addition, at least on an annual basis, the Company
contracts with an external loan review company to review the
internal credit ratings assigned to loans in the commercial loan
portfolio on a pre-determined schedule, based on the type, size,
rating, and overall risk of the loan. During the course of its
review, the third party examines a sample of loans, including new
loans, existing relationships over certain dollar amounts and
classified assets.
The following table presents our loans by risk rating for the
periods indicated:
|
|
Commercial Real Estate |
|
|
Residential 1-4 Family |
|
|
Home Equity |
|
|
Commercial and Industrial |
|
|
Consumer |
|
|
Total |
|
|
|
(In thousands) |
|
March 31, 2022 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pass (Rated 1 – 4) |
|
$ |
973,892 |
|
|
$ |
560,425 |
|
|
$ |
99,891 |
|
|
$ |
199,763 |
|
|
$ |
4,232 |
|
|
$ |
1,838,203 |
|
Special Mention (Rated 5) |
|
|
47,729 |
|
|
|
— |
|
|
|
— |
|
|
|
7,464 |
|
|
|
— |
|
|
|
55,193 |
|
Substandard (Rated 6) |
|
|
17,866 |
|
|
|
3,914 |
|
|
|
274 |
|
|
|
8,715 |
|
|
|
20 |
|
|
|
30,789 |
|
Total |
|
$ |
1,039,487 |
|
|
$ |
564,339 |
|
|
$ |
100,165 |
|
|
$ |
215,942 |
|
|
$ |
4,252 |
|
|
$ |
1,924,185 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2021 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pass (Rated 1 – 4) |
|
$ |
913,063 |
|
|
$ |
547,980 |
|
|
$ |
99,503 |
|
|
$ |
215,605 |
|
|
$ |
4,228 |
|
|
$ |
1,780,379 |
|
Special Mention (Rated 5) |
|
|
48,765 |
|
|
|
— |
|
|
|
— |
|
|
|
2,777 |
|
|
|
— |
|
|
|
51,542 |
|
Substandard (Rated 6) |
|
|
18,141 |
|
|
|
4,352 |
|
|
|
256 |
|
|
|
8,287 |
|
|
|
22 |
|
|
|
31,058 |
|
Total |
|
$ |
979,969 |
|
|
$ |
552,332 |
|
|
$ |
99,759 |
|
|
$ |
226,669 |
|
|
$ |
4,250 |
|
|
$ |
1,862,979 |
|
6. GOODWILL
AND OTHER INTANGIBLES
Goodwill.
At
March 31, 2022 and December 31, 2021, the Company’s goodwill was
related to the acquisition of Chicopee in October 2016. There was
no goodwill impairment recorded during the three months ended March
31, 2022 or the year ended December 31, 2021. Annually, or more
frequently if events or changes in circumstances warrant such
evaluation, the Company evaluates its goodwill for
impairment.
Core
Deposit Intangible.
In
connection with the acquisition of Chicopee, the Bank recorded a
core deposit intangible of $4.5 million which
is amortized over twelve
years using the straight-line method. Amortization expense
was $94,000 for
the three months ended March 31, 2022 and $93,000
for the three months ended March 31, 2021. At March 31, 2022,
future amortization of the core deposit intangible totaled
$375,000
for each of the next five years and $594,000
thereafter.
7.
SHARE-BASED
COMPENSATION
Stock
Options.
A summary of stock option activity for the three months ended March
31, 2022 is presented below:
|
|
|
Shares |
|
|
Weighted Average Exercise Price |
|
|
Weighted
Average
Remaining
Contractual
Term
(in
years)
|
|
|
Aggregate
Intrinsic
Value
(in
thousands)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding
at December 31, 2021 |
|
|
|
177,881 |
|
|
$ |
6.57 |
|
|
|
0.81 |
|
|
$ |
388 |
|
Exercised |
|
|
|
(80,881 |
) |
|
|
6.29 |
|
|
|
0.43 |
|
|
|
211 |
|
Outstanding
at March 31, 2022 |
|
|
|
97,000 |
|
|
$ |
6.80 |
|
|
|
0.81 |
|
|
$ |
206 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercisable
at March 31, 2022 |
|
|
|
97,000 |
|
|
$ |
6.80 |
|
|
|
0.81 |
|
|
$ |
206 |
|
Cash
received for options exercised during the three months ended March
31, 2022 and 2021 was $510,000 and
$113,000,
respectively.
Restricted
Stock Awards.
In
May 2014, the Company’s shareholders approved the 2014 Omnibus
Incentive Plan, a stock-based compensation plan (the “2014 RSA
Plan”). Under the 2014 RSA Plan, up to 516,000 shares of the Company’s
common stock were reserved for grants of stock awards, including
stock options and restricted stock, which may be granted to any
officer, key employee or non-employee director of WNEB. Any shares
that are not issued because vesting requirements are not met were
available for future issuance under the 2014 RSA Plan.
On an
annual basis, the Compensation Committee (the “Committee”) approves
long-term incentive awards out of the 2014 RSA Plan, whereby shares
will be granted to eligible participants of the Company that are
nominated by the Chief Executive Officer and approved by the
Committee, with vesting over a three-year term for
employees and a one-year term for
directors. Annual employee grants provide for a periodic award that
is both performance and time-based and is designed to recognize the
executive’s responsibilities, reward performance and leadership and
as a retention tool. The objective of the award is to align
compensation for the named executive officers and directors over a
multi-year period directly with the interests of our shareholders
by motivating and rewarding creation and preservation of long-term
financial strength, shareholder value and relative shareholder
return.
In
February 2019, 108,718 shares were granted. Of the
108,718 shares, 64,496 shares were time-based, with
20,262 vesting in one year and 44,234 vesting ratably over a
three-year period.
The remaining 44,222 shares granted are
performance-based and are subject to the achievement of the 2019
long-term incentive performance metric. The primary performance
metric for 2019 grants was return on equity. Performance shares
will be earned based upon how the Company performs relative to
threshold, target and maximum absolute goals (i.e.
Company-specific, not relative to a peer index) on an annual
performance period, but will be distributed at the end of the
three-year
period.
The
threshold, target and stretch metrics under the 2019 grants are as
follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Return on
Equity Metrics |
|
Performance
Period Ending |
|
|
|
Threshold |
|
|
|
Target |
|
|
|
Stretch |
|
December
31, 2019 |
|
|
|
5.75 |
% |
|
|
6.13 |
% |
|
|
7.00 |
% |
December
31, 2020 |
|
|
|
6.00 |
% |
|
|
6.75 |
% |
|
|
7.75 |
% |
December
31, 2021 |
|
|
|
6.25 |
% |
|
|
7.00 |
% |
|
|
8.00 |
% |
Eligible
participants will be able to earn between 50%
(“threshold” performance),
100% (“target” performance) and
150% (“maximum” performance). As of December 31, 2021, the
three-year performance period for the 2019 grants ended. The 2019
long term incentive plan included a “catch-up” provision allowing
unearned performance-based shares from the 2019 and 2020
performance periods to be earned at the end of the three-year
period based on the final year performance. Of the original
44,222 performance-based shares granted in 2019, 40,003 shares
were eligible for vesting based on achieving target. Because of the
“catch-up” provision within the plan, 60,009 performance-based
shares vested and were issued to eligible recipients in February
2022 based on achieving stretch for each performance
period.
In
February 2020,
120,053 shares were granted. Of the
120,053 shares,
69,898 shares were time-based, with
19,760 vesting in
one year and
50,138 vesting ratably over a three-year period.
The remaining
50,155 shares granted are performance-based and are subject
to the achievement of the 2020 long-term incentive performance
metrics, with 50% of the performance-based
shares vesting for each performance metric. The primary performance
metrics for the 2020 grants are return on equity and earnings per
share. Performance shares will be earned based upon how the Company
performs relative to threshold, target and maximum absolute goals
(i.e. Company-specific, not relative to a peer index) on an annual
performance period for return on equity metrics and for a three-year cumulative
performance period for earnings per share, but will be distributed
at the end of the three-year period as
earned.
The
threshold, target and stretch metrics under the 2020 grants are as
follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Return on
Equity Metrics |
|
Performance
Period Ending |
|
|
|
Threshold |
|
|
|
Target |
|
|
|
Stretch |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December
31, 2020 |
|
|
|
5.00 |
% |
|
|
5.48 |
% |
|
|
6.00 |
% |
December
31, 2021 |
|
|
|
5.62 |
% |
|
|
6.24 |
% |
|
|
6.86 |
% |
December
31, 2022 |
|
|
|
6.29 |
% |
|
|
6.99 |
% |
|
|
7.69 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings Per Share Metrics |
|
Performance Period Ending |
|
|
Threshold |
|
|
Target |
|
|
Stretch |
|
|
|
|
|
|
|
|
|
|
|
|
Three-year Cumulative Diluted Earnings Per Share |
|
|
$ |
1.50 |
|
|
$ |
1.65 |
|
|
$ |
1.80 |
|
Eligible
participants will be able to earn between
50% (“threshold” performance),
100% (“target” performance) and
150% (“maximum” performance).
The
fair market value of shares awarded is based on the market price at
the grant date, recorded as unearned compensation and amortized
over the applicable vesting period. Performance-based metrics are
monitored on a quarterly basis in order to compare actual results
to the performance metric, with any necessary adjustments being
recognized through share-based compensation expense and unearned
compensation.
In
February 2021,
19,827 shares were granted to our directors, with a
one-year vesting
period. At December 31, 2021, there were no remaining shares
available to grant under the 2014 RSA Plan.
In
May 2021, the Company’s shareholders approved the 2021 Omnibus
Incentive Plan, a stock-based compensation plan (the “2021 RSA
Plan”). Under the 2021 RSA Plan, up to
700,000 shares of the Company’s common stock were reserved
for grants of stock awards, including stock options and restricted
stock, which may be granted to any officer, key employee or
non-employee director of the Company. Any shares that are not
issued because vesting requirements are not met will be available
for future issuance under the 2021 RSA Plan.
In
May 2021,
122,362 shares were granted. Of the
122,362 shares,
61,181 shares were time-based, vesting ratably over a
three-year period.
The remaining
61,181 shares granted are performance-based and are subject
to the achievement of the 2021 long-term incentive performance
metrics, with
50% of the performance-based shares vesting for each
performance metric. The primary performance metrics for the 2021
grants are return on equity and earnings per share. Performance
shares will be earned based upon how the Company performs relative
to threshold, target and maximum absolute goals (i.e.
Company-specific, not relative to a peer index) on an annual
performance period for return on equity metrics and for a three-year cumulative
performance period for earnings per share, but will be distributed
at the end of the three-year period as
earned.
The
threshold, target and stretch metrics under the 2021 grants are as
follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Return on Equity Metrics |
|
Performance Period Ending |
|
|
Threshold |
|
|
Target |
|
|
Stretch |
|
|
|
|
|
|
|
|
|
|
|
|
December
31, 2021 |
|
|
|
5.63 |
% |
|
|
6.25 |
% |
|
|
7.50 |
% |
December
31, 2022 |
|
|
|
5.85 |
% |
|
|
6.50 |
% |
|
|
7.80 |
% |
December
31, 2023 |
|
|
|
6.08 |
% |
|
|
6.75 |
% |
|
|
8.10 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings Per Share Metrics |
|
Performance Period Ending |
|
|
Threshold |
|
|
Target |
|
|
Stretch |
|
|
|
|
|
|
|
|
|
|
|
|
Three-year Cumulative Diluted Earnings Per Share |
|
|
$ |
1.58 |
|
|
$ |
1.97 |
|
|
$ |
2.36 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
In
March 2022,
137,151 shares were granted. Of the
137,151 shares,
77,463 shares were time-based, with
17,775 vesting in
one year and
59,688 vesting ratably over a three-year period.
The remaining
59,688 shares granted are performance-based and are subject
to the achievement of the 2022 long-term incentive performance
metrics, with
50% of the performance-based shares vesting for each
performance metric. The primary performance metrics for the 2022
grants are return on equity and earnings per share. Performance
shares will be earned based upon how the Company performs relative
to threshold, target and maximum absolute goals (i.e.
Company-specific, not relative to a peer index) on an annual
performance period for return on equity metrics and for a three-year cumulative
performance period for earnings per share, but will be distributed
at the end of the three-year period as
earned.
The
threshold, target and stretch metrics under the 2022 grants are as
follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Return on Equity Metrics |
|
Performance Period Ending |
|
|
Threshold |
|
|
Target |
|
|
Stretch |
|
|
|
|
|
|
|
|
|
|
|
|
December
31, 2022 |
|
|
|
7.79 |
% |
|
|
8.20 |
% |
|
|
8.61 |
% |
December
31, 2023 |
|
|
|
7.93 |
% |
|
|
8.35 |
% |
|
|
8.77 |
% |
December
31, 2024 |
|
|
|
8.03 |
% |
|
|
8.45 |
% |
|
|
8.87 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings Per Share Metrics |
|
Performance Period Ending |
|
|
Threshold |
|
|
Target |
|
|
Stretch |
|
|
|
|
|
|
|
|
|
|
|
|
Three-year Cumulative Diluted Earnings Per Share |
|
|
$ |
2.35 |
|
|
$ |
2.61 |
|
|
$ |
2.85 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
At
March 31, 2022, there were 440,487 remaining shares
available to grant under the 2021 RSA Plan.
A
summary of the status of restricted stock awards at March 31, 2022
and 2021 is presented below:
|
|
|
Shares |
|
|
Weighted Average Grant Date Fair Value |
|
Balance
at December 31, 2021 |
|
|
|
213,381 |
|
|
$ |
8.91 |
|
Shares
granted |
|
|
|
144,440 |
|
|
|
9.14 |
|
Shares
forfeited |
|
|
|
(6,651 |
) |
|
|
8.66 |
|
Shares
vested |
|
|
|
(60,009 |
) |
|
|
9.77 |
|
Balance
at March 31, 2022 |
|
|
|
291,161 |
|
|
$ |
8.85 |
|
|
|
|
Shares |
|
|
Weighted Average Grant Date Fair Value |
|
Balance
at December 31, 2020 |
|
|
|
178,766 |
|
|
$ |
9.63 |
|
Shares
granted |
|
|
|
19,827 |
|
|
|
8.17 |
|
Shares
forfeited |
|
|
|
(19,154 |
) |
|
|
11.05 |
|
Shares
vested |
|
|
|
(27,727 |
) |
|
|
9.81 |
|
Balance
at March 31, 2021 |
|
|
|
151,712 |
|
|
$ |
9.23 |
|
We
recorded total expense for restricted stock awards of $301,000 and $231,000
for the three months ended March 31, 2022 and 2021,
respectively.
8.
SHORT-TERM
BORROWINGS AND LONG-TERM DEBT
Total
borrowing capacity includes borrowing arrangements at the FHLB, the
Federal Reserve Bank (“FRB”), and borrowing arrangements with
correspondent banks.
The
Company is a member of the FHLB and uses borrowings as an
additional source of funding to finance the Company’s lending and
investing activities and to provide liquidity for daily operations.
FHLB advances also provide more pricing and option alternatives for
particular asset/liability needs. The FHLB provides a central
credit facility primarily for member institutions. As an FHLB
member, the Company is required to own capital stock of the FHLB,
calculated periodically based primarily on its level of borrowings
from the FHLB. FHLB borrowings are secured by certain securities
from the Company’s investment portfolio not otherwise pledged as
well as certain residential real estate and commercial real estate
loans. Advances are made under several different credit programs
with different lending standards, interest rates and range of
maturities. This relationship is an integral component of the
Company’s asset-liability management program. At March 31, 2022,
the Bank had $464.1 million in additional
borrowing capacity from the FHLB.
The
Company also has an available overnight Ideal Way line of credit
with the FHLB of $9.5 million as of
March 31, 2022. Interest on this line of credit is payable at a
rate determined and reset by the FHLB on a daily basis. The
outstanding principal is due daily but the portion not repaid will
be automatically renewed. As of March 31, 2022 and December 31,
2021, there were no advances outstanding under this
line.
The
Company has an available line of credit of $5.7 million with the
FRB Discount Window at an interest rate determined and reset on a
daily basis. Borrowings from the FRB Discount Window are secured by
certain securities from the Company’s investment portfolio not
otherwise pledged. As of March 31, 2022 and December 31, 2021,
there were no advances outstanding under this line.
The
Company also has pre-established, non-collateralized overnight
borrowing arrangements with large national and regional
correspondent banks to provide additional overnight and short-term
borrowing capacity for the Company. The Company has a $15.0 million line of
credit with a correspondent bank and a $50.0 million line of
credit with another correspondent bank, both at an interest rate
determined and reset on a daily basis. As of March 31, 2022 and
December 31, 2021, there were no advances outstanding under these
lines.
Long-term
debt consists of FHLB advances with an original maturity of one
year or more. At March 31, 2022, we had $1.7 million in long-term debt with
the FHLB, compared to $2.7 million in long-term debt with
the FHLB at December 31, 2021.
9.
SUBORDINATED
DEBT
On
April 20, 2021, the Company completed an offering of $20 million in aggregate principal
amount of its 4.875% fixed-to-floating rate
subordinated notes (the “Notes”) to certain qualified institutional
buyers in a private placement transaction.
Unless
earlier redeemed, the Notes mature on May 1, 2031. The Notes will bear
interest from the initial issue date to, but excluding, May 1, 2026, or the earlier
redemption date, at a fixed rate of
4.875% per annum, payable quarterly in arrears on May 1,
August 1, November 1 and February 1 of each year, beginning August
1, 2021, and from and including May 1, 2026, but excluding the
maturity date or earlier redemption date, equal to the benchmark
rate, which is the 90-day average secured overnight financing
rate, plus 412 basis points,
determined on the determination date of the applicable interest
period, payable quarterly in arrears on May 1, August 1, November 1
and February 1 of each year. The Company may also redeem the Notes,
in whole or in part, on or after May 1, 2026, and at any
time upon the occurrence of certain events, subject in each case to
the approval of the Board of Governors of the Federal Reserve
System (the “Federal Reserve”). The Notes were designed to qualify
as Tier 2 capital under the Federal Reserve’s capital adequacy
regulations.
The
Notes are presented net of issuance costs of $357,000 as of March 31, 2022, which
is being amortized into interest expense over the life of the
Notes. Amortization of issuance costs into interest expense was
$10,000
for the three months ended March 31, 2022.
10.
PENSION
BENEFITS
We
provide a defined benefit pension plan for eligible employees (the
“Plan”). Employees must work a minimum of 1,000
hours per year to be eligible for the Plan. Eligible employees
become vested in the Plan after five years of service. We plan to
contribute to the Plan the amount required to meet the minimum
funding standards under Section 412 of the Internal Revenue Code of
1986, as amended. Additional contributions will be made as deemed
appropriate by management in conjunction with the Plan’s actuaries.
We have not yet determined how much we expect to contribute to the
Plan in 2022. No contributions have been made to the Plan for the
three months ended March 31, 2022. The Plan’s assets are invested
in various pooled separate investment accounts offered by Principal
Life Insurance Company, a division of Principal Financial Group,
who is the custodian of the Plan. The Plan is administered by an
officer of Westfield Bank. On September 30, 2016, we effected a
soft freeze on the Plan and therefore no new participants will be
included in the Plan after such effective date.
The following table provides information regarding net pension
benefit costs for the periods shown:
|
|
|
|
|
|
|
|
|
|
|
Three
Months Ended
March
31,
|
|
|
|
2022 |
|
|
2021 |
|
|
|
(In thousands) |
|
Service cost |
|
$ |
334 |
|
|
$ |
454 |
|
Interest cost |
|
|
313 |
|
|
|
295 |
|
Expected return on assets |
|
|
(427 |
) |
|
|
(439 |
) |
Amortization of actuarial loss |
|
|
158 |
|
|
|
234 |
|
Net periodic pension cost |
|
$ |
378 |
|
|
$ |
544 |
|
11.
DERIVATIVES AND
HEDGING ACTIVITIES
Risk
Management Objective of Using Derivatives.
The
Company is exposed to certain risks arising from both our business
operations and economic conditions. We principally manage our
exposures to a wide variety of business and operational risks
through management of our core business activities. We manage
economic risks, including interest rate, liquidity, and credit
risk, primarily by managing the amount, sources, and duration of
our assets and liabilities and the use of derivative financial
instruments. Specifically, we entered into derivative financial
instruments to manage exposures that arise from business activities
that result in the receipt or payment of future known and uncertain
cash amounts, the value of which are determined by interest rates.
Our derivative financial instruments are used to manage differences
in the amount, timing, and duration of our known or expected cash
receipts and our known or expected cash payments principally
related to certain variable rate loan assets and variable rate
borrowings.
The following table presents information about interest rate swaps
at March 31, 2022 and December 31, 2021:
March 31, 2022 |
|
Notional |
|
|
Weighted Average |
|
|
Weighted Average Rate |
|
|
Fair |
|
|
|
Amount |
|
|
Maturity |
|
|
Receive |
|
|
Pay |
|
|
Value |
|
|
|
(In thousands) |
|
|
(In years) |
|
|
|
|
|
|
|
|
(In thousands) |
|
Non-hedging derivatives: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loan-level swaps – dealer counterparties |
|
$ |
15,951 |
|
|
|
10.9 |
|
|
|
2.13 |
% |
|
|
3.76 |
% |
|
$ |
449 |
|
Loan-level swaps – borrower counterparties |
|
|
15,951 |
|
|
|
10.9 |
|
|
|
3.76 |
% |
|
|
2.13 |
% |
|
|
(449 |
) |
Forward starting loan-level swaps - dealer counterparties |
|
|
22,390 |
|
|
|
10.3 |
|
|
|
|
|
|
|
|
|
|
|
2,363 |
|
Forward starting loan-level swaps - borrower counterparties |
|
|
22,390 |
|
|
|
10.3 |
|
|
|
|
|
|
|
|
|
|
|
(2,363 |
) |
Total |
|
$ |
76,682 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
0 |
|
December 31,
2021 |
|
Notional |
|
|
Weighted Average |
|
|
Weighted Average Rate |
|
|
Fair |
|
|
|
Amount |
|
|
Maturity |
|
|
Receive |
|
|
Pay |
|
|
Value |
|
|
|
(In thousands) |
|
|
(In years) |
|
|
|
|
|
|
|
|
(In thousands) |
|
Non-hedging derivatives: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loan-level swaps – dealer counterparties |
|
$ |
16,023 |
|
|
|
11.1 |
|
|
|
1.99 |
% |
|
|
3.76 |
% |
|
$ |
(662 |
) |
Loan-level swaps – borrower counterparties |
|
|
16,023 |
|
|
|
11.1 |
|
|
|
3.76 |
% |
|
|
1.99 |
% |
|
|
662 |
|
Forward starting loan-level swaps - dealer counterparties |
|
|
22,390 |
|
|
|
10.5 |
|
|
|
|
|
|
|
|
|
|
|
1,030 |
|
Forward starting loan-level swaps - borrower counterparties |
|
|
22,390 |
|
|
|
10.5 |
|
|
|
|
|
|
|
|
|
|
|
(1,030 |
) |
Total |
|
$ |
76,826 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
0 |
|
Cash
Flow Hedges of Interest Rate Risk.
The
Company’s objectives in using interest rate derivatives are to add
stability to interest income and expense and to manage its exposure
to interest rate movements. To accomplish these objectives, we
entered into interest rate swaps as part of our interest rate risk
management strategy. These interest rate swaps are designated as
cash flow hedges and involve the receipt of variable rate amounts
from a counterparty in exchange for our making fixed
payments.
For
derivatives designated as cash flow hedges, the changes in the fair
value of the derivative is initially reported in other
comprehensive income (outside of earnings), net of tax, and
subsequently reclassified to earnings when the hedged transaction
affects earnings. We are hedging our exposure to the variability in
future cash flows for forecasted transactions over a maximum period
of six years (excluding forecasted payment of variable interest on
existing financial instruments).
Non-hedging
Derivatives.
Derivatives
not designated as hedges are not speculative, but rather result
from a service the Company provides to certain customers. The
Company executes loan level derivative products such as
interest-rate swap agreements with commercial banking customers to
aid them in managing their interest-rate risk by converting
floating-rate loan payments to fixed-rate loan payments. The
Company concurrently enters into offsetting swaps with a third
party financial institution, effectively minimizing its net risk
exposure resulting from such transactions. The third-party
financial institution exchanges the customer's fixed-rate loan
payments for floating-rate loan payments. As the interest-rate swap
agreements associated with this program do not meet hedge
accounting requirements, changes in the fair value are recognized
directly in earnings.
Fair
Values of Derivative Instruments on the Balance
Sheet.
The table below presents the fair value of our derivative financial
instruments not designated as hedging instruments as well as our
classification on the balance sheet as of March 31, 2022 and
December 31, 2021.
March
31, 2022 |
|
Asset Derivatives |
|
Liability Derivatives |
|
|
Balance Sheet Location |
|
Fair Value |
|
Balance Sheet Location |
|
Fair Value |
|
|
|
(In thousands) |
Derivatives not designated as hedging instruments: |
|
|
|
|
|
|
|
|
|
Interest rate swap – with borrower counterparties |
|
|
|
$ |
0 |
|
|
|
$ |
2,812 |
|
Interest rate swap – with dealer counterparties |
|
|
|
|
2,812 |
|
|
|
|
0 |
|
Total derivatives not designated as hedging instruments |
|
Other Assets |
|
$ |
2,812 |
|
Other Liabilities |
|
$ |
2,812 |
|
December
31, 2021 |
|
Asset Derivatives |
|
Liability Derivatives |
|
|
Balance Sheet Location |
|
Fair Value |
|
Balance Sheet Location |
|
Fair Value |
|
|
|
(In thousands) |
Derivatives not designated as hedging instruments: |
|
|
|
|
|
|
|
|
|
Interest rate swap – with borrower counterparties |
|
|
|
$ |
662 |
|
|
|
$ |
1,030 |
|
Interest rate swap – with dealer counterparties |
|
|
|
|
1,030 |
|
|
|
|
662 |
|
Total derivatives not designated as hedging instruments |
|
Other Assets |
|
$ |
1,692 |
|
Other Liabilities |
|
$ |
1,692 |
|
Effect
of Derivative Instruments in the Consolidated Statements of Net
Income and Changes in Shareholders’ Equity.
There
were gains or losses recognized in accumulated other comprehensive
income during the three months ended March 31, 2021 or
2020.
Amounts
reported in accumulated other comprehensive loss related to cash
flow hedge derivatives are reclassified to interest expense as
interest payments are made on our designated rate sensitive
liabilities. The
table below presents the amount reclassified from accumulated other
comprehensive loss into net income for interest rate swaps and
termination fees:
|
|
Amount of Loss Reclassified from OCI into Expense (Effective
Portion) |
|
|
|
Three Months Ended March 31, |
|
|
|
|
|
|
|
|
|
|
2022 |
|
|
2021 |
|
|
|
|
|
|
|
|
|
|
Interest rate swaps |
|
$ |
0 |
|
|
$ |
140 |
|
As of
December 31, 2021, the Company no longer has any outstanding cash
flow hedges.
Credit-risk-related Contingent Features
By
using derivative financial instruments, we expose ourselves to
credit risk. Credit risk is the risk of failure by the counterparty
to perform under the terms of the derivative contract. When the
fair value of a derivative contract is positive, the counterparty
owes us, which creates credit risk for us. When the fair value of a
derivative is negative, we owe the counterparty and, therefore, it
does not possess credit risk. The credit risk in derivative
instruments is mitigated by entering into transactions with
highly-rated counterparties that we believe to be creditworthy and
by limiting the amount of exposure to each counterparty.
We
have agreements with our derivative counterparties that contain a
provision where if we default on any of our indebtedness,
including default where repayment of the indebtedness has
not been accelerated by the lender, then we could also be
declared in default on our derivative obligations. We also have
agreements with certain of our derivative counterparties that
contain a provision where if we fail to maintain our status as well
capitalized, then the counterparty could terminate the derivative
positions and we would be required to settle our obligations under
the agreements. Certain of our agreements with our derivative
counterparties contain provisions where if a formal administrative
action by a federal or state regulatory agency occurs that
materially changes our creditworthiness in an adverse manner, we
may be required to fully collateralize our obligations under the
derivative instrument.
At
March 31, 2022, we had minimum collateral posting thresholds with
certain of our derivative counterparties. As of March 31, 2022, we
were not required to post collateral under these agreements because
we did not have any derivatives in a liability position with those
counterparties.
12.
FAIR VALUE OF
ASSETS AND LIABILITIES
Determination
of Fair Value.
We
use fair value measurements to record fair value adjustments to
certain assets and liabilities and to determine fair value
disclosures. The fair value of a financial instrument is the price
that would be received to sell an asset or paid to transfer a
liability in an orderly transaction between market participants at
the measurement date. Fair value is best determined based upon
quoted market prices. However, in many instances, there are no
quoted market prices for our various financial instruments. In
cases where quoted market prices are not available, fair values are
based on estimates using present value or other valuation
techniques. Those techniques are significantly affected by the
assumptions used, including the discount rate and estimates of
future cash flows. Accordingly, the fair value estimates may not be
realized in an immediate settlement of the instrument.